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Identifying small for gestational age (SGA) and large for gestational age (LGA) 
babies is important, because these babies may be at increased risk of hypoglycaemia 
at birth.  It is proposed that customised birthweight centiles (CBWC) can more 
accurately identify these babies by taking into account several physiological 
variables of the pregnancy affecting birthweight.  These variables are: maternal 
height and booking weight, ethnicity, parity, the baby’s gender and gestation.  
CBWC for a New Zealand (NZ) population were developed by McCowan, Stewart, 
Francis and Gardosi (2004), and can be downloaded for free from 
www.gestation.net.  Using CBWC is not in common practice in NZ, even though its 
use was discussed in a 2007 Health and Disability Commissioner report in relation 
to neonatal hypoglycaemia.  The setting for the study was a NZ District Health 
Board (DHB) that calculates a CBWC for each birth.  The research question asked 
how the evidence behind CBWC was put into practice and what outcomes resulted 
from translating this knowledge into action.  This was a mixed methods evaluation 
which included interviews, focus groups, an audit and document analysis.  The 
knowledge-to-action (KTA) framework (Straus, Tetroe, & Graham, 2009) was used 
as a theoretical template to describe the implementation process that occurred.  The 
results revealed that maternity care providers were initially challenged by the 
evidence.  But over time, guideline compliance improved as practitioners 
experienced the benefit of using CBWC in practice.  All agreed that the CBWC 
calculator was user-friendly.  However, the audit demonstrated it was easy to make a 
mistake or manipulate results when using the calculator.  CBWC can help identify 
babies at risk of hypoglycaemia who otherwise would have been missed.  But it is 
unknown what difference it had made in improving neonatal morbidity and 
mortality, due to insufficient data.  But anecdotally, stakeholders felt it had made a 
difference.  The findings demonstrated that knowledge translation is a complex 
process which is difficult to capture within a one-dimensional framework.  However, 
using such a framework can identify what stages are needed to complete an 
implementation process.   
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Chapter One: Introduction 
 
When a baby is born, its birthweight is measured and an assessment is made to 
determine whether this weight is within a ‘normal’ range for the gestation.  One 
reason why this is important is that babies who are either small or large for their 
gestation may be at risk of hypoglycaemia (Holtrop, 1993).  Consequently, the 
method used to define small for gestational age (SGA) and large for gestational age 
(LGA) is crucial.  It sets the threshold by which a newborn’s blood sugar levels 
(BSL) will be monitored.  Traditionally, cut-off points of <2500 g and >4500 g were 
used to identify SGA and LGA babies.  But this only considers birthweight.  
Birthweight centiles are another tool commonly used.  They consider gestation in 
addition to birthweight and are usually sex-adjusted.  But often birthweight centile 
charts developed from a given population are then inappropriately applied to 
populations with different characteristics.  Alternatively, customised birthweight 
centiles (CBWC) take into account birthweight as well as a number of variables of 
the pregnancy to give an ‘individualised’ or ‘customised’ centile for that baby.  
These variables are the mother’s ethnicity, parity, height, booking weight and the 
baby’s gender and gestation (McCowan, et al., 2004).  The evidence shows that 
using a ‘customised’ centile will more accurately identify babies inappropriately 
grown for their gestation who are at increased risk of adverse perinatal events (De 
Jong, Gardosi, Dekker, Colenbrander, & Van Geijn, 1998).  This should be 
considered in assessing a baby’s risk of neonatal hypoglycaemia. 
 
To explain this further it is helpful to consider this scenario.  A mother having her 
first baby gives birth to a 3 kg (6.6 lb) baby boy on her due date.  Would you 
consider her baby to be an appropriate size?  What if you also knew the mother was 
European, 157 cm (5ft 2”) and had a booking weight of 50 kg?  Or what if the 
mother was Tongan, 170 cm (5ft 7”) and had a booking weight of 120 kg?  Would 
your opinion about the size of the baby change depending on who the mother was?  
Taking all these variables (maternal ethnicity, parity, height, booking weight and 
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baby gender and gestation) into consideration the European baby would have a 
CBWC of 19.  The Tongan baby would have a CBWC of 2.  If SGA is defined by a 
CBWC being less than 10, then only the Tongan baby would be identified as SGA.  
The Tongan baby would be considered at risk of hypoglycaemia and would have its 
BSL monitored.  The European baby would be identified as appropriately grown for 
its gestation.  It would not be considered at risk of hypoglycaemia and would not 
have its BSL monitored.   
 
The concept of using customisation to accurately identify growth restricted babies is 
a relevant and timely issue, as demonstrated by the most recent Perinatal and 
Maternal Mortality Review Committee (PMMRC) report (PMMRC, 2011).  Using 
CBWC they found “SGA was evident in 41 percent of perinatal related deaths at 24 
weeks or beyond … 42 percent of stillborn babies and 26 percent of neonates whose 
deaths were not due to congenital abnormality.  This [was] significantly more 
frequent than the expected rate of 10 percent” (PMMRC, 2011, p. 55).  As a result 
the PMMRC have recommended the use of customised growth charts in pregnancy 
(PMMRC, 2011).  CBWC which are calculated at birth have not yet been nationally 
recommended and their application in NZ remains limited.   
 
This thesis explores the use of CBWC in clinical practice.  It looks at why and how 
CBWC were implemented at one NZ DHB.  It also examines the results of 
implementing this change in practice.  In wanting to describe what happened in a 
meaningful way, a knowledge translation framework was chosen to provide the 
theoretical foundation needed to interpret and analyse the processes that occurred.  
The study was a mixed methods process-outcome evaluation, overlayed with the 
knowledge-to-action (KTA) framework to explain the processes of implementation.  
After utilising the framework, it was decided that comment could also be made 
about the usefulness of the framework when applied to a clinical practice issue 
retrospectively.  This resulted in a double layered thesis.  In the forefront the focus is 
on the issue of using CBWC in clinical practice.  In the background the usefulness of 
  3 
 
a knowledge translation framework is also highlighted.  This thought process led to 
the development of the following Research Question and Objectives:   
 
Research Question 
How was the evidence behind the use of customised birthweight centiles (CBWC) 
put into practice at one New Zealand District Health Board (NZ DHB) and what 




• To identify and critique the evidence relating to the use of CBWC 
• To describe how CBWC were implemented at one NZ DHB 
• To evaluate the processes followed when utilising CBWC 
• To identify outcomes relating to babies identified as SGA or LGA using 
CBWC 
• To evaluate the usefulness of the knowledge-to-action framework when 
applied to a clinical practice issue 
 
The remainder of this introductory chapter will provide the background to how 
‘normal’ birthweight has been defined and why this is important in relation to 
assessing risk of neonatal hypoglycaemia.  The relevance of these issues will be 
explored by examining a Health and Disability Commissioner (HDC) report in 
which the Commissioner asked how practitioners can better identify babies at risk of 
hypoglycaemia based on their birthweight. 
 
Defining ‘normal’ birthweight  
The history of defining ‘normal’ birthweight has been inadequate and haphazard at 
best.  In 1948 the First World Health Assembly accepted the definition for pre-
maturity as a birthweight ≤2500 g and this was adopted almost universally to 
identify infants requiring special care (World Health Organization, 1961).  In the 
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1950’s an expert group recognised this definition wasn’t applicable in some 
countries and that birthweight needed to be correlated with gestation (World Health 
Organization, 1961).  It was recognised this standard overwhelmed the resources of 
some hospitals, so the birthweight was lowered to locally adapt the definition 
(World Health Organization, 1961).  This meant there was no longer a uniform 
definition for babies requiring special care based on their birthweight.   
 
Another expert committee found that “there is in reality no sharp dividing line 
between mature and premature babies or between high and low birth weight babies” 
(World Health Organization, 1961, p. 6).  But due to the lack of basic data they were 
not able to clarify this definition further.  Instead they recommended the definition 
of ≤2500 g be changed from defining pre-maturity to that of low birth weight (World 
Health Organization, 1961).  Gestation was not included as part of this classification.  
This definition of ≤2500 g, then became commonly used to identify SGA babies, 
with LGA babies commonly identified as those >4500 g (Health and Disability 
Commissioner, 2007).  Defining ‘normal’ birthweight is important because babies 
who are inappropriately grown for their gestation may be at increased risk of 
hypoglycaemia at birth.  The way ‘normal’ birthweight is defined provides one 
criteria for which babies will be monitored for hypoglycaemia in the immediate 
newborn period. 
 
Hypoglycaemia in the newborn 
Hypoglycaemia occurs when low blood sugar levels (BSL) are present.  In the 
newborn, undetected hypoglycaemia can lead to irreversible brain damage.  “In 
newborns at risk, hypoglycaemia is most likely to occur in the first 24 hours of life, 
as the infant adapts to extrauterine life” (World Health Organization, 1997, p. 1).  
Glucose levels are the lowest 1-2 hours after birth.  But a healthy term infant has a 
normal physiological response called counterregulation (World Health Organization, 
1997), which can increase BSL above 2.5 mmol/L (Rozance & Hay, 2006).  A BSL 
concentration maintained around 2.5 mmol/L is generally accepted as a ‘safe’ level 
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(Wight, Marinelli, & The Academy of Breastfeeding Medicine Protocol Committee, 
2006).  But selecting an ‘unsafe’ level below which neurological damage will occur, 
remains highly debatable.  
 
A consistent definition of hypoglycaemia does not exist in the literature (Rozance & 
Hay, 2006).  Cornblath et al., (2000) state that “the definition of clinically significant 
hypoglycaemia remains one of the most confused and contentious issues in 
contemporary neonatology” (p. 1141).  In addition there is no definitive time frame 
known in which neurological injury can occur (Rozance & Hay, 2006).  This is 
because deciding whether a BSL is ‘safe’ or not is influenced by birthweight, 
gestation, postnatal age and feeding method.  So any definition would likely be too 
rigid to apply universally (World Health Organization, 1997).  Therefore “all that 
can be proposed are pragmatic intervention thresholds that also provide a margin of 
safety” (Cornblath, et al., 2000, p. 1143).  Hypoglycaemia may indicate that 
malnutrition in-utero has occurred (Gardosi, Mongelli, & Mul, 1995).  Except for 
babies born to mothers with poorly controlled diabetes, hypoglycaemia is more 
common in growth restricted babies than any other group (Halliday, 2009).   
 
Some SGA babies are unable to produce an adequate metabolic and endocrine 
response to hypoglycaemia (Cornblath, et al., 2000).  SGA babies may be at 
increased risk of hypoglycaemia due to a high brain to body mass ratio, reduced fat 
stores and hyperinsulinism (World Health Organization, 1997).  A baby identified as 
SGA will have its BSL closely monitored in an attempt to prevent some degree of 
morbidity or possible mortality (Goldenberg & Cliver, 1997).  But there is a lack of 
research on how to more precisely identify SGA babies and the incidence and 
outcomes of hypoglycaemia in these babies (World Health Organization, 1997).  
The risks of hypoglycaemia for LGA babies are discussed to a lesser degree in the 
literature. 
 
Metabolic studies have not been as extensively studied in LGA infants (World 
Health Organization, 1997), but macrosomia may be associated with a higher risk of 
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neonatal hypoglycaemia (Wollschlaeger, Nieder, Koppe, & Hartlein, 1999).  A baby 
who is physiologically LGA has proportionate increases in brain size and abdominal 
circumference.  Whereas a LGA baby born to a diabetic mother will have increased 
fat, muscle and liver mass due to the effects of increased insulin (World Health 
Organization, 1997).  LGA babies have previously been considered ‘at risk’ as it 
was believed they represented babies born to mothers with undiagnosed diabetes 
(Wight, et al., 2006).  But this view remains controversial.  Some have suggested 
that all LGA babies of non diabetic mothers should be monitored for 
hypoglycaemia, but for a shorter period (Holtrop, 1993).  While others believe 
routine glucose monitoring should be performed on all LGA babies of non-diabetic 
mothers (Schaefer-Graf et al., 2002).  More recently the literature favours LGA 
babies not being considered ‘at risk’ when maternal diabetes is absent  (UNICEF, 
2008).  This means screening women for diabetes in pregnancy can eliminate LGA 
as a risk factor for those babies which are physiologically versus pathologically 
large.   
 
The Health and Disability Case (Case 05HDC16723) 
Birthweight as a risk factor for neonatal hypoglycaemia was highlighted by a recent 
HDC case.  The report was a timely reminder for DHBs around the importance of 
identifying babies at risk and recognising, then rectifying, hypoglycaemia.  In this 
case (Health and Disability Commissioner, 2007) a 2735 g male baby was born at 
38+5 weeks gestation by caesarean section for foetal distress in early labour.  The 
mother smoked in pregnancy and was taking the anti-depressant Aropax.  Although 
the baby breastfed well initially, by Day Three the baby was reluctant to feed and 
became hypoglycaemic.  Despite intervention at this point the baby was unable to 
maintain adequate BSL.  Due to the period of hypoglycaemia, the baby suffered 
severe neurological problems.  Expert midwifery opinion for the case confirmed the 
baby’s birthweight of 2735 g would have been considered normal, as <2500 g was 
the cut-off for SGA and low birthweight babies in many hospitals.   
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“Weight of 2500 gms would have been used as a cut off point in 
2004 rather than customised growth charts to assess individual 
growth.  Customised growth charts are not a normal assessment tool 
in all hospital/units within NZ even in 2007.  He therefore was not 
considered to be at risk of hypoglycaemia” (Health and Disability 
Commissioner, 2007, p. 20). 
 
 
Although the term customised growth charts (GCG) was used by the expert midwife, 
in relation to identifying the normality of a baby’s birthweight, a customised 
birthweight centile (CBWC) would provide a more accurate guide of appropriate 
growth at birth for a given gestation, rather than the CGC.  CGC are used 
antenatally, whereas CBWC are calculated at birth.  A CGC therefore estimates 
foetal growth in pregnancy based on serial plotted fundal height measurements.  But 
a CBWC gives a ‘customised’ birthweight centile based on the actual birthweight.  
But both CGC and CBWC were developed from the same software. Throughout the 
HDC report CGC is referred to when mentioning the baby’s birthweight of 2735 g.  
But to provide the correct context for the comments made in the report, it would 
have been more accurate for CBWC to be referred to in relation to considering 
whether the baby’s birthweight was ‘normal’.  In his final opinion the Commissioner 
states, “I am advised that the customised growth charts [CBWC], which are a more 
reliable guide for staff [in identifying birthweight as a risk factor], are even now not 
in common usage throughout New Zealand” (Health and Disability Commissioner, 
2007, p. 31).  The HDC findings were sent to all DHB CEO’s and other national 
organisations for educational purposes.  This case highlighted the need for DHBs to 
review their neonatal hypoglycaemic management policies and how they identified 
babies ‘at risk’.  It also proposed using CBWC to assess individual birthweight as 
part of that risk assessment. 
 
Better identifying babies at risk of hypoglycaemia due to 
their birthweight 
 
A study in the 1970’s found that episodes of hypoglycaemia were being missed in 
some babies who were >2500 g.  These babies had likely experienced intra-uterine 
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malnutrition and their actual birthweight fell short of its genetic potential (Oakley & 
Parsons, 1977).  They determined that more research needed to be completed to see 
whether it was possible to predict which infants >2500 g would suffer from neonatal 
hypoglycaemia and to determine an objective measure of malnourishment in babies 
>2500 g (Oakley & Parsons, 1977).  Since then others have also realised that 
assessment of gestational age and appropriateness of size for gestation should be a 
part of determining this risk (Rozance & Hay, 2006).  Perhaps CBWC, which 
considers the optimum growth potential of a baby by taking a number of variables of 
the pregnancy into account, could be the ‘objective measure’ referred to. 
 
My person practice perspective 
My midwifery career began in 2005 and I have worked as a caseload midwife in the 
community and a hospital-based midwife within secondary and tertiary settings.  
During this time I also became a mother and commenced my postgraduate studies.  I 
am a Maori midwife who developed a love of learning from my parents and I view 
ongoing education as an important part of my personal and professional 
development.  I had always wanted to complete a piece of research and publish the 
findings in a journal.  While working as a midwife I looked for an interesting topic 
to research relating to clinical practice.  As a student and then a qualified midwife, I 
observed that people were often resistant to changing the way they practiced.  Often 
midwives reasoned they had always done it that way and saw no reason to change.  I 
also noticed that DHBs had different ways of practicing even though each guideline 
claimed to be ‘evidenced-based’.  One policy difference I noticed was how SGA and 
LGA babies were identified in relation to their risk of hypoglycaemia.  I work at a 
DHB who use cut-off birthweights at varying gestations adapted from population 
centile charts.  I later became aware of another DHB who were using CBWC.  I 
wondered what the rationale was for using either method.  I also wondered which 
method was more successful at identifying babies at risk of hypoglycaemia based on 
birthweight.   
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I chose CBWC as the topic for my thesis because using customisation to identify 
growth restricted babies is a contemporary issue.  The majority of health 
practitioners I’ve spoken with have never heard of CBWC.  So it appeared the DHB, 
that was using CBWC was innovative and pioneering in their use of CBWC.  I 
wondered why this DHB chose to use CBWC and what difference it had made in the 
outcomes for babies.  There didn’t appear to be any studies describing the practical 
issues around implementing CBWC.  There were no studies which investigated the 
use of CBWC to identify risk of hypoglycaemia in the newborn.  So I believed the 
findings of my research could potentially be of significant interest to a number of 
health professionals. 
 
Structure of the thesis 
This thesis tells the story of how one NZ DHB implemented CBWC at their 
maternity unit.  The thesis is divided into six chapters. This introductory chapter has 
provided the background of how using birthweight to identify risk of hypoglycaemia 
is relevant and how a recent HDC case highlighted this issue.  Chapter Two 
discusses the evidence that exists for using customised standards, which led to the 
development of CBWC.  Chapter Three will discuss the concept of knowledge 
translation and introduce the knowledge-to-action theoretical framework used as a 
research tool.  Chapter Four will provide the justification for selecting a mixed 
methods evaluation approach and describes the overall research design and methods.  
The results of the research will be presented in Chapter Five.  Chapter Six will 
elaborate on some of the more significant findings, including discussing 
implications, recommendations and ideas for further research.  The thesis ends with 
an overall conclusion and numerous appendices have been attached which are 
referred to throughout the thesis. 
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Summary 
The history of how ‘normal’ birthweight and hypoglycaemia have been defined is 
haphazard and controversial.  Each definition depends on a number of variables and 
no single definition is applicable to all clinical scenarios.  The importance of 
recognising birthweight as a risk factor for hypoglycaemia was highlighted by a 
HDC case where a baby developed irreversible brain damage.  The Commissioner 
noted that using CGC was a more reliable guide for staff, but in the context of the 
report in relating to identifying risk based on birthweight, what should have been 
discussed was the use of CBWC as a more reliable guide for staff.  The use of 
CBWC is still not common practice within NZ DHBs.  This topical issue interested 
me as I was aware of one NZ DHB who calculated a CBWC after every birth.  I 
wanted to investigate why and how they implemented CBWC and the outcomes 
resulting from this change.  It is hoped this thesis will cause individuals and DHBs 
to consider the value of CBWC as a clinical tool in assessing the normality of 
birthweight and its relationship with the risk of neonatal hypoglycaemia.  In the next 
section I will explain in detail what CBWC are and how they were developed.  The 
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Chapter Two: Customised Birthweight Centiles 
Introduction 
Over the last 50 years the importance of considering gestation when defining 
‘normal’ birthweight has been recognised (World Health Organization, 1961).  
Additionally, a number of physiological and pathological maternal and foetal 
variables are known to affect birthweight (Gardosi, Mongelli, Wilcox, & Chang, 
1995).  This chapter introduces some of the terminology used to define appropriate 
birthweight and how it relates to the way ‘small’ and ‘large’ babies are identified.   It 
discusses how the GROW (Gestation Related Optimum Weight) software was 
developed.  This was then used to create customised growth charts (CGC) which 
monitor foetal growth in pregnancy and customised birthweight centiles (CBWC) 
which are calculated at birth.  The findings from the main studies on customising 
standards are presented.  The majority of the studies conclude that using CBWC as a 
classification standard results in more accurately identifying those babies who are 
truly growth-restricted, or pathologically large.  This represents babies that are at 
increased risk of perinatal morbidity and mortality.  Finally a timeline is also 
presented to show how long it took for this evidence to be implemented at the DHB 
in this research study. 
 
Understanding the terminology 
The terms IUGR (intrauterine growth restriction), SGA (small for gestational age) 
and LBW (low birth weight) are often used interchangeably.  SGA babies are also 
sometimes known as small for dates (SFD).  While it is possible that a baby might 
be all of these, this may not necessarily be true.  IUGR is a “reduced growth in 
relation to the fetus’ genetic potential and small for date infants may be the result of 
individual normal genetic variation rather than poor growth” (Ego et al., 2006, p. 
1042).  IUGR babies are labelled according to an antenatal assessment of their 
growth, whereas SGA babies are labelled according to an assessment of their 
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birthweight (Maulik, 2006).  A LBW baby is born at term (≥37 weeks) weighing 
<2500 g (World Health Organization, 1961).  LGA (large for gestational age) babies 
are also labelled according to an assessment of their birthweight.  Definitions of 
macrosomic (large) babies range from >4,000 g to >5000 g regardless of gestation, 
with ≥4500 g most commonly used (Heiskanen, Raatikainen, & Heinonen, 2006).  
Comprehending the subtle differences between some of these definitions is 
important in understanding how these terms relate to CGC and CBWC.  For 
example, CGC identifies foetal growth restriction in pregnancy (IUGR) and CBWC 
identifies foetal growth restriction at birth (SGA).  It is important that the correct 
terminology is used and understood in the appropriate context relating to how 
‘small’ and ‘large’ babies are identified. 
 
Accurately identifying SGA and LGA babies 
SGA babies have an increased risk of perinatal morbidity and mortality and at the 
other extreme LGA babies have a similar increased risk of morbidity (Beeby, 
Bhutap, & Taylor, 1996).  Choosing the most accurate method to identify these 
babies at birth is important as this will determine which ones require additional care.  
Some methods, to determine which babies require additional care, but not 
considering gestation have been developed such as: weight to length ratios, ratios of 
anthropometric measurements, neonatal skinfold thickness, body fat and body 
composition (Goldenberg & Cliver, 1997).  But most traditionally a baby <2500 g or 
>4500 g has been considered SGA or LGA.  Population centile charts are sometimes 
used which take gestation into consideration and are usually sex-adjusted.  
Population centile chart cut-off points have been arbitrarily chosen to define SGA at 
the 10th, 5th or 3rd centile or two standard deviations below the mean (Gardosi, 
2009a).  A cut-off below the 10th centile for a given gestation is the most common 
definition applied for SGA babies (Maulik, 2006).  The most common cut-off for 
LGA babies is above the 90th centile (Gardosi, Chang, Kalyan, Sahota, & Symonds, 
1992).  But the reliability of these classification methods have been questioned when 
applied to populations with varying characteristics.  It has been proposed that 
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CBWC are more appropriate to use (Zhang, Platt, Cnattingius, Joseph, & Kramer, 
2007).  CBWC take several maternal and foetal characteristics relating to the 
pregnancy into consideration which ‘customises’ a birthweight centile for each 
individual baby.  A cut-off centile still needs to be selected to identify a baby as 
SGA or LGA.  But the centile will be ‘customised’ for that baby, instead of being 
based on conventional population standards. 
 
CBWC as a classification standard 
CBWC appear to be a more accurate measure because they consider the baby’s 
potential for growth, rather than using arbitrary cut-off points based on population 
standards.   
 
A customised birthweight centile reflects a greater range of 
physiologic characteristics of the pregnancy namely: booking 
weight, height, parity, ethnicity and infant gestation at delivery 
and sex.  Using these data the centile calculator generates a 
customised birthweight centile for that individual baby. 
(McCowan & Stewart, 2004, p. 435)  
 
Using unadjusted population centiles will lead to a number of at risk babies being 
missed and a number of babies being incorrectly identified (Gardosi, Clausson, & 
Francis, 2009).  In their original study, Gardosi et al., (1992), found that when 
physiological variables are not taken into account around a quarter of babies 
identified as SGA or LGA were false-positives.  These babies would have been 
physiologically rather than pathologically small or large.  They also found that 
around a quarter of babies who should be SGA or LGA weren’t identified when 
using conventional centiles.   
 
This is demonstrated in Figure 1 below, which represents all SGA babies in a given 
population and how they would be identified if CBWC were used as a classification 
method versus sex-adjusted population centiles.  One subset of the population will 
be identified as SGA by CBWC only; one subset will be identified as SGA by both 
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methods and another subset will be identified as SGA by sex-adjusted population 
centiles only.  The SGA by CBWC only subset will consist of babies who are 
pathologically small and who otherwise would have been missed.  These babies 
would have been considered as having a normal birthweight on a population based 
centile chart, but are actually growth restricted (Cowan, 2009).  The SGA by sex-
adjusted population centiles only subset will consist of babies who would have been 
considered false-positives.  If based on CBWC they would not have been identified 
as growth restricted.  A similar figure could be drawn to represent all LGA babies in 
a given population.  (Note: In Figure 1 the size of the circles and overlap is not 




Figure 1.    The classification of SGA babies by CBWC vs sex-adjusted population 
birthweight centiles 
 
CBWC are a more reliable classification method as it defines ‘normal’ birthweight 
by the optimal growth potential of each individual baby (Gardosi, 2006).  Using 
CBWC can reduce unnecessary intervention and decrease parental anxiety by 
identifying babies that are truly pathologically small or large for their gestation 
(Gardosi, et al., 1992).  CBWC predicts an optimal birthweight based on a number 
 
SGA by  
CBWC only 





SGA   
by 
both 
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of maternal and foetal variables.  The software programme GROW was used to 
develop CBWC which considered these variables.     
 
The development of ‘GROW’ (Gestation Related Optimum 
Weight) 
 
The development of the GROW software by Gardosi et al., (1992) built upon 
previous concepts of individualised growth charts, but included factors that 
influenced the growth potential of the baby in-utero.  It has been said that 
“birthweight is a biological variable with corresponding variability” (Bakketeig & 
Magnus, 1992, p. 140), meaning that birthweight is influenced by a number of 
factors.  Factors such as smoking, low socio-economic status, pre-eclampsia and 
diabetes were found to have a pathological influence on birthweight.  So they were 
not included in the development of GROW as they were trying to predict a baby’s 
growth within an optimum environment (Gardosi, 2009b).  The variables: gestation, 
foetal sex, booking weight, height, ethnicity and parity were shown to be 
independent determinants of birthweight and were included in the model (Gardosi et 
al., 1992).  GROW determined the level of influence these variables had on 
birthweight.   
Gestation and Parity 
As early as the 1960’s it was understood that gestation influenced whether a 
birthweight should be considered ‘normal’ (World Health Organization, 1961).  It 
was identified that infants of similar birthweight, but different gestational age, 
developed dissimilar clinical problems (Battaglia & Lubchenco, 1967).  Various 
classification systems based on birthweight and gestation were therefore proposed.  
Battaglia and Lubchenco (1967) divided gestational age into three divisions referred 
to as Pre-Term, Term and Post-Term and this determined which type of nursery care 
the baby received.  This made it easier to identify which babies were SGA and LGA.  
Other birthweight centile charts were developed which took into account whether 
previous births were SGA or LGA.  This reflected “the tendency to repeat weight for 
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gestation in successive births” (Bakketeig & Magnus, 1992, p. 142).  It is known that 
gestation has the strongest influence on birthweight of about 20g per day at term 
(Gardosi, Mongelli, & Mul, 1995).  So accurately dating pregnancies and calculating 
gestation is important.  Parity is also a statistically significant determinant of 
birthweight (Voorhorst, Bouter, Bezemer, & Kurver, 1993).  And it has been shown 
that infants of nulliparous women weigh less than infants of multiparous women 
(Goldenberg & Cliver, 1997).   
Sex and Ethnicity 
Male infants on average weigh more than female infants (Goldenberg & Cliver, 
1997).  In developing NZ birthweight centiles one study found that at each gestation 
week, male babies were approximately 100g heavier than female babies (Thompson, 
Mitchell, & Borman, 1994).  McCowan and Stewart (2004) also found that there 
were significant differences in birthweights across NZ ethnic groups.  Tongan and 
Samoan babies were found to be significantly heavier than all other ethnic groups.  
The understanding that ethnicity has a significant effect on birthweight has long 
been recognised (Grundy, Hood, & Newman, 1978).  Obvious differences between 
ethnic groups have been found as various birthweight databases were developed 
(Gardosi, Mongelli, Wilcox, et al., 1995).  This variation in birthweight across 
ethnicities supports the argument that “continued use of birthweight standards 
derived from predominantly European or Caucasian populations for all racial/ethnic 
groups is clearly undesirable” (Gardosi, et al., 1992, p. 286).  It has also been 
suggested that these differences appear to be mainly the result of characteristics such 
as maternal height and weight (Voorhorst, et al., 1993).   
Maternal Height and Weight 
In the 1960’s it was recognised that birthweight was influenced by maternal height 
and weight.  After gestation, maternal weight at booking was shown to have the 
strongest correlation with birthweight (World Health Organization, 1961).  This 
correlation extends further in that there is a significant difference between the 
average height and weight for mothers of SGA and non-SGA babies.  Not 
surprisingly, smaller mothers are more likely to have smaller babies (De Jong, et al., 
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1998).  Alternatively, Cnattingius, Bergstrom, Lipworth and Kramer (1998), found 
that a higher maternal weight protects against having a SGA baby.  This research 
was based on population rather than customised standards and this finding was 
disputed by Gardosi, Clausson and Francis (2007).  They found that using 
population standards underestimates the contribution of obesity to SGA risk.  They 
also found that a high maternal body mass index (BMI) is associated with an 
increased number of SGA babies when customised centiles are used (Gardosi & 
Francis, 2009a).  A high BMI is an important risk factor which should be identified 
early in pregnancy (McCowan, et al., 2004).  Increases in maternal BMI are directly 
proportional to perinatal mortality (Gardosi, et al., 2009).  This is one risk factor of 
pregnancy which is preventable (Cnattingius, et al., 1998).  Smoking in pregnancy is 
another preventable risk factor, which women have the ability to influence.   
Smoking  
Smoking has a significant and independent growth restricting effect (Gardosi, 
Mongelli, Wilcox, et al., 1995) and has a “dose-response relationship” with 
birthweight (Gardosi, 2009a, p. 742).  Because this effect is pathological, expectant 
birthweight should be calculated as if the mother was a non-smoker (Gardosi, 
Mongelli, Wilcox, et al., 1995).  The GROW software takes this into account and 
“the resultant growth curve … represents an ideal standard for each individual 
pregnancy, which would be more sensitive for identifying any growth retardation 
due to smoking” (Gardosi, Mongelli, Wilcox, et al., 1995, p. 173).  A mother who 
smokes does not provide the optimal environment in which their baby is expected to 
grow and this has a significant effect on birthweight. 
 
It was already known that birthweight standards needed to be developed for the 
specific population they are applied to (Sloan & Lorenz, 1991).  So “to optimise 
antenatal growth screening and assessment, the physiological variables that are 
known to affect birthweight also need to be applied to fetal weight curves” (Gardosi, 
Mongelli, Wilcox, et al., 1995, p. 173).  The GROW software achieved this by 
taking physiological variables affecting birthweight into consideration and was then 
used to create CGC and CBWC.   
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Customised Growth Charts (CGC) 
Gardosi et al., (1995) set out to make a model that could provide an adjustable foetal 
weight standard, by which a predicted ideal birthweight could be measured against 
the observed birthweight.  This meant the median and centile values of a growth 
chart were not fixed, as the values could be affected by different characteristics.  
They were able to combine these maternal characteristics and previous birthweights 
with a “standard, longitudinal ultrasound-derived curve for intrauterine weight gain” 
to create a “computer-generated antenatal chart that can be easily “customised” for 
each individual pregnancy” (Gardosi, et al., 1992, p. 283).  The software programme 
can be downloaded for free from www.gestation.net for UK, Australian, NZ and 
USA populations, with other international versions being developed.  Maternal 
variables entered into the programme at the first antenatal visit will generate a chart 
(Figure 2), which can be used to monitor foetal growth throughout the pregnancy. 
 
             
Figure 2.  A customised antenatal growth chart (Gardosi, 2009a, p. 743) 
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The use of CGC has been recommended by the PMMRC for all pregnancies in NZ 
to improve the recognition of foetal growth restriction antenatally (PMMRC, 2011).  
While fundal heights are plotted on a CGC throughout pregnancy, a CBWC is 
calculated in the postnatal period once the actual birthweight is known.     
 
Customised Birthweight Centiles (CBWC) 
The CBWC calculator can also be downloaded for free from www.gestation.net 
(Figure 3).  The calculator is used by selecting a value from each of the drop down 
menus corresponding to each variable and a CBWC is automatically calculated.  
Figure 3 demonstrates the data values from the birth of my first child, giving a 
CBWC of 19.   
 
 
Figure 3.  A customised birthweight centile calculator (www.gestation.net) 
 
 
Adjusting any of the data values will accordingly change the CBWC result.  In this 
example changing ethnicity to Tongan gives a CBWC of 10.  Changing gestation to 
39 weeks increases the CBWC to 53.  Increasing the booking weight to 90 kg lowers 
the CBWC to 7.  A ‘normal’ CBWC is determined by the cut-off centile level and 
will likely vary across maternity providers.  A cut-off below the 10th centile is the 
most common definition applied for SGA (Maulik, 2006) and a cut-off above the 
90th centile for LGA babies (Gardosi, et al., 1992).  The DHB in the study defined a 
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SGA baby as having a CBWC less than the 10th centile and a LGA baby as having a 
CBWC greater than the 95th centile.  Therefore, any CBWC value in the range of 10 
to 95 was considered normal at the DHB.   
 
Using CBWC has been recommended by the British Royal College of Obstetricians 
and Gynaecologists (Hutcheon, Zhang, Cnattingius, Kramer, & Platt, 2008).  It has 
also been suggested that American obstetricians adopt the use of customised foetal 
growth standards in customising birthweight (Resnik, 2007).  The PMMRC 
calculates a CBWC for all foetal deaths in NZ when analysing perinatal mortality 
data and define SGA as a CBWC less than the 10th centile (PMMRC, 2011).  But 
their application has not yet been recommended nationally, even though a CBWC 
calculator for NZ is currently available.  
  
Development of CBWC for a NZ population 
McCowan and Stewart (2004) determined that differences in birthweight across 
major ethnic groups in NZ were significant.  They developed NZ ethnic specific 
birthweight centile charts (for gestations 38 to 41 weeks) for both sexes.  The 10th 
and 90th percentile was calculated for ethnicities and the cut-off points were found 
to be different (McCowan & Stewart, 2004).  This was the first study to report 
birthweight centiles for common ethnic groups in NZ.  Part of this data was applied 
to the GROW software and used to develop CGC and a CBWC calculator for a NZ 
population.  When applied to the model, half of the data had to be disregarded 
because maternal weight and/or height weren’t available.  They concluded that 
maternal height and weight at booking had to be routinely collected before 
customised centiles could be fully applied in a NZ setting (McCowan, et al., 2004).  
While the CBWC calculator is readily available, many practitioners are unaware of 
CBWC and the numerous studies advocating for the ‘customising’ of standards.   
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The evidence for and against ‘customising’ standards 
The GROW software was used to develop both CGC and CBWC.  Therefore an 
argument supporting or opposing ‘customising’ standards in the antenatal period 
would also be applicable to the postnatal period.  The main studies from a range of 
countries which provides the evidence for and against using ‘customised’ standards 
verses population based standards are outlined in Table 1 below.  These studies are 
all examples of retrospective reviews of population databases.  There are no 
randomised control trials.  The majority of these studies were about customisation 
being used to identify SGA babies.  Only one study specifically mentioned LGA 
babies.  Most studies advocated the use of customised standards as the most accurate 
method.  A few studies provided arguments against the use of customisation, but 
their findings have since been critiqued by the original authors of the research which 
was being challenged.     
 
Studies advocating the use of customisation found that babies identified as SGA 
using customised standards had the highest rates of perinatal morbidity and mortality 
(De Jong, et al., 1998; Gardosi & Francis, 2009a).  This included a higher risk of 
stillbirth and neonatal death (Clausson, Gardosi, Francis, & Cnattingius, 2001; Ego, 
et al., 2006; Gardosi, et al., 2009).  For other measures of perinatal morbidity and 
mortality, there were similar rates in the SGA by customisation only group and the 
SGA by both methods group (McCowan, Harding, & Stewart, 2005).  Babies 
identified as SGA using population centiles only, had levels of perinatal morbidity 
similar to a non-SGA population (Clausson, et al., 2001).  This relates back to Figure 
1 (p. 14) introduced earlier in this chapter which illustrated three different subsets of 
babies identified as SGA using CBWC versus sex-adjusted population centiles.  The 
CBWC group uses ‘customised’ standards, versus the sex-adjusted population 
centile group which uses population standards.  The common conclusion of the 
studies was that customised centiles are better at truly identifying babies ‘at risk’ of 
adverse perinatal outcomes due to their birthweight (Clausson, et al., 2001; Gardosi, 
et al., 2009).  Therefore, customising standards improves the diagnosis of growth 
restriction (Groom, Poppe, North, & McCowan, 2007). 
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Studies arguing against customising standards were around issues relating to the 
customisation technique of Gardosi et al., (1992).  Some believed the effect of 
several variables had been incorrectly estimated, which produced an exaggerated 
increase in perinatal risk (Zhang, et al., 2007).  Zhang et al., (2007) said that the 
finding of an increase in the risk of perinatal mortality observed with customised 
centiles was ‘largely an artefact’ and due to a higher proportion of preterm babies 
identified as SGA.  But Gardosi et al., (2007) explained that “gestational age 
patterns become apparent when the appropriate standard is used.  They are of 
interest in the study of adverse outcomes in pregnancy and are hardly an artefact” 
(Gardosi, et al., 2007, p. 1301).  McCowan et al., (2007) also argued that the ability 
of customised centiles to identify an increased proportion of SGA infants born 
preterm is in fact one of the important advantages of using customised centiles over 
population centiles.  Hutcheon et al., (2008) argued that customising for maternal 
variables makes little difference.  But Gardosi and Francis (2009a) argued Hutcheon 
et al., (2008) had only partially applied their model, which would have affected the 
results.  Finally, Ego et al., (2008) found that excluding parity from customising 
SGA babies made no difference in identifying high risk babies (Ego, et al., 2008).  
Gardosi et al., (2009) performed their own analysis to measure the effect of perinatal 
mortality risk associated with parity.  They commented that Ego et al., (2008), had 
failed to look at the whole parity spectrum and that when all parity groups are 
considered, customising SGA babies better reflects perinatal mortality risk (Gardosi 
& Francis, 2009c).   
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Table 1.  Studies providing the evidence for and against using ‘customised’ standards verses population based standards 
Authors and Title Type of study Results and Conclusions 
Studies advocating using customised standards: 







in the UK. 
• Using adjusted centiles 28% of babies designated SGA and 22% of those designated LGA were 
actually within normal limits for the pregnancy.  
• 24% and 25% of babies identified as SGA or LGA with adjusted centiles were not identified by 
conventional unadjusted centiles.   
• Babies who were SGA by conventional unadjusted centiles only, had significantly fewer 
instances of low Apgar scores.  
   
(De Jong, et al., 1998) 
Application of a 
customised birthweight 
standard in the assessment 
of perinatal outcome in a 




217 babies from 
high risk 
pregnancies in the 
Netherlands. 
• Customising resulted in an increase of SGA babies from 14% to 31%. 
• Customised centiles significantly improves the identification of infants who have failed to reach 
the expected birthweight and are at increased risk for adverse perinatal outcomes eg C-section 
for foetal distress, NICU admission, ventilation, apgar <7 at 5 min, pHa ≤ 7.15, stillbirth etc 
   
(Clausson, et al., 2001) 
Perinatal outcome in SGA 







326,377 births in 
Sweden. 
• Risk of stillbirth, neonatal death and apgar score <4 at 5 mins were higher if SGA was classified 
by customised vs population based birthweight standards.   
• Compared to population based centiles, customised standards are better at identifying 
foetuses with growth restriction associated with an increased risk of adverse perinatal outcome.   
• Babies SGA by population standards, but not by customised standards, have little or no 
increase in perinatal mortality. 
   
(McCowan, et al., 2005) 
Customised birthweight 
centiles predict SGA 









• Abnormal Doppler studies, nursery admission, long hospital stay, pre-eclampsia in the mother 
and C-section for foetal distress, were less common in the population SGA only group. 
• No perinatal deaths occurred in the population SGA only group. 
• There were similar rates of perinatal morbidity and mortality between the customised SGA 
only group and SGA both (customised and population) group. 
• Using customised centiles is more likely to detect more babies at risk of perinatal morbidity 
and mortality than using population centiles. 
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(Ego, et al., 2006) 
Customized versus 
population-based birth 
weight standards for 
identifying growth 





56,606 births in 
France. 
• CBWC identified a group of infants (3%) that would otherwise be considered appropriate for 
gestational age using population standards.  These infants had an increased risk of stillbirth and 
perinatal death compared to non SGA babies. 
• Individual growth norms adjusted for maternal and neonatal characteristics to identify 
foetuses at risk should be used to define SGA. 
   
(Groom, et al., 2007) 
SGA infants classified by 
customised or population 
birthweight centiles: 








• Customised centiles classified more infants as SGA, compared with population centiles, in 
preterm births but not for term births.  This reflects the association of preterm birth with 
placental disease and growth restriction.   
• Perinatal deaths for preterm births only occurred in those classified as customised SGA.   
• Population SGA only infants have low rates of morbidity and mortality, with perinatal 
outcomes similar to non-SGA infants. 
• Using customised centiles to identify SGA infants, especially preterm infants, is important as 
they are more likely to identify truly growth restricted infants.  
   
(Gardosi & Francis, 2009a) 
Adverse pregnancy 
outcome and association 
with small for gestational 








35,235 births in 
the USA. 
• Babies by customised SGA showed a higher risk for threatened preterm labour, antepartum 
haemorrhage, pregnancy-induced hypertension, preeclampsia, stillbirth and early neonatal 
death, compared with SGA by population standards. 
• Customised SGA differentiates between physiologically and pathologically small babies.   
   
(Gardosi, et al., 2009) 
The value of customised 
centiles in assessing 
perinatal mortality risk 






records in Sweden. 
• SGA rates identified by customised centiles showed a strong association with perinatal 
mortality rates. 
• Using customised centiles to determine SGA improves the identification of pregnancies at 
increased risk of perinatal death. 
• Customising for parity and maternal size results in a standard that has a substantially 
strengthened association with perinatal mortality risk. 
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Studies arguing against using customised standards: 
(Zhang, et al., 2007) 
The use of customised 
versus population-based 






782,303 births in 
Sweden. 
• The increased risks associated with SGA babies classified by customised standards is due to the 
inclusion of a large proportion of preterm births, as customised standards will classify a higher 
proportion of preterm infants as SGA. 
   
(Hutcheon, et al., 2008) 
Customised birthweight 






782,303 births in 
Sweden. 
• The overall improved prediction of mortality when using customised birthweight charts may be 
due to methodological differences between intrauterine and conventional charts, as customising 
for maternal characteristics makes little difference.  
• A non-customised intrauterine weight standard has a similar ability to predict perinatal 
morbidity and mortality as a customised birthweight standard. 
   
(Ego, et al., 2008) 
Should parity be included 
in customised fetal weight 
standards for identifying 
SGA babies? Results from a 





51,126 births in 
France. 
• Adjusting for parity markedly decreases the proportion of primigravida with SGA babies, but 
doesn’t appear to improve the identification of high risk babies. 
• Removing parity will simplify the Gardosi et al., model of customisation and remove the 
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The literature was overwhelmingly in favour of the evidence advocating for the use 
of standards based on customisation, rather than population based standards.  But 
while the evidence for customisation exists, it has yet to be routinely applied in 
clinical practice.   
 
Putting the ‘evidence’ into practice 
Although the evidence exists to show that customisation improves the diagnosis of 
growth restriction, its use in practice remains limited (Maulik, 2006).  There is often 
a time lag between evidence being produced and then incorporated into practice 
(Hanberg & Brown, 2006).  While using CGC is recommended by the PMMRC in 
NZ, it is unknown how widespread their use is.  NZ was one of the first countries to 
apply the evidence and develop a CBWC calculator specific to their population 
(McCowan, et al., 2004).  The DHB in this study, which implemented CBWC, 
understood they were the only DHB in NZ calculating a CBWC for every birth.  The 
time taken for CBWC to be put into practice at this DHB in demonstrated in Table 2.  
It took 17 years from when CGC were first developed for CGC to be recommended 
by the PMMRC.  It also took 12 years for a CBWC calculator to be developed for a 
NZ population.  From this point, it took an additional three years for the DHB to use 
CBWC, which was not long after it was discussed as part of a HDC case.   
 
Table 2.  Timeline for putting the evidence behind CBWC into practice at one NZ DHB 
Timeline Milestone  Publication date 
Customised antenatal growth charts developed (Gardosi, et al., 
1992). 
 February 1992 
   
CBWC developed for a NZ population (McCowan, et al., 2004).  October 2004 
   
HDC report expressing concern over DHB’s not using CBWC (Health 
and Disability Commissioner, 2007). 
 September 2007 
   
CBWC initially implemented at the DHB in the study.   October 2007  
   
Guidelines and a flowchart incorporating CBWC finalised at the 
DHB in the study, after much debate. 
 March 2008 
   
First recommendation by PMMRC to complete CGC for every 
pregnancy in NZ (PMMRC, 2009). 
 March 2009 




CBWC for an Australian population was first published in April 2007 (Mongelli, 
Figueras, Francis, & Gardosi, 2007).  CGC developed for a US population was first 
published in July 2009 (Gardosi & Francis, 2009b).  This shows that the NZ and the 
DHB in this study were ahead of other countries in developing their own customised 
standards and then applying them in practice.   
 
Summary 
The GROW software determined the degree of influence a number of physiological 
variables of pregnancy had on birthweight.  This software was then used to create 
customised growth charts (CGC) and customised birthweight centiles (CBWC).  
Fundal heights are plotted on CGC and identify growth restriction antenatally by 
predicting birthweight.  CBWC are calculated at birth using the actual birthweight.  
Using CBWC versus sex-adjusted population centiles will result in picking up SGA 
and LGA babies who previously would have been missed and decreases the number 
of false positives.  Customisation will result in identifying babies that are 
pathologically rather than physiologically small or large.  The majority of the studies 
showed using customised standards are a more accurate way of identifying babies 
that are truly growth restricted.  And babies identified as SGA by CBWC only, have 
the highest rates of perinatal morbidity and mortality.  Nevertheless, this evidence 
hasn’t been put into practice to the degree recommended.  The next chapter will 
discuss knowledge translation theory which is about putting knowledge into action.  
It then introduces a conceptual knowledge translation framework which was used as 
a research tool for this study.   
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Chapter Three: Knowledge Translation 
Introduction 
A CBWC calculator developed for a NZ population has been available since 2004 
(McCowan, et al., 2004).  However, a 2007 HDC case highlighted the fact that this 
evidence has not been put into practice in NZ.  The Commissioner asked why a gap 
existed between the evidence available and what was seen in clinical practice.  This 
chapter discusses knowledge translation theory, which is related to putting the action 
back into evidence based practice.  The knowledge-to-action (KTA) framework is 
introduced which illustrates the ideal phases required for knowledge translation to 
occur.  Frameworks can help us to make sense of complex processes.  Therefore, the 
KTA framework was selected to help describe the processes involved with the 
implementation of CBWC at the NZ DHB studied.   
 
Knowledge Translation 
A unpublished literature search conducted by McKibbon and colleagues, found more 
than 90 different terms to describe how research is used (McKibbon, 2009, as cited 
in Straus, Tetroe, & Graham, 2009).  Terminology such as: knowledge uptake, 
implementation science and practice change are used.  But the term knowledge 
translation is increasingly used today.  Knowledge translation is defined as: 
 
A dynamic and iterative process that includes the synthesis, 
dissemination, exchange and ethically sound application of 
knowledge to improve health, provide more effective health services 
and products, and strengthen the health care system. (Straus, Tetroe, 
& Graham, 2009, p. 165) 
 
Knowledge translation occurs in response to curiosity and is about problem solving 
with a purpose (Landry, Amara, Pablos-Mendes, Shademani, & Gold, 2006).  It uses 
the best knowledge available (World Health Organization, 2006), which is evidence 
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based.  The concept of knowledge translation promotes a culture of learning, critical 
thinking, innovation and change.  It recognises that moving from knowledge to 
action is not a one-way process (World Health Organization, 2006).  Knowledge 
translation is not a ‘state’ or ‘end product’ and is constantly changing (Graham & 
Tetroe, 2009).  It depends on people and context (Landry, et al., 2006) and the 
culture of the organisation in which the knowledge is being applied (Graham & 
Tetroe, 2009).  Knowledge translation cannot happen on its own.  It “requires careful 
planning, implementation and monitoring with people who are engaged in and 
committed to change” (Graham & Tetroe, 2009, p. 158).  Also integral to its success 
is the need to consider the various stakeholders or end-users of the knowledge being 
implemented (Straus, Tetroe, & Graham, 2009).  The key elements required for 
knowledge translation have been put together visually by Graham et al., (2006), in a 
knowledge-to-action (KTA) framework (Figure 4).   
 
Figure 4.   The knowledge-to-action framework (Straus, Tetroe, & Graham, 
2009, p. 167) 
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The knowledge-to-action (KTA) framework 
The KTA framework was first published in 2006 by Graham et al. (2006).  The 
framework was developed from the similarities found in reviewing planned action 
theories (Straus, Tetroe, & Graham, 2009).  It was created to help make sense of the 
phenomenon of knowledge translation, by providing a map to guide the application 
of knowledge into action (Graham & Tetroe, 2010).  The authors believed that 
“given the action cycle’s grounding in planned action theory, the framework can be 
considered evidence-informed” (Graham & Tetroe, 2010, p. 212).  They also 
acknowledged they were unaware of any studies evaluating the framework itself.   
 
The framework (Figure 4) illustrates the two processes of knowledge creation and 
knowledge application.  The middle funnel symbolises knowledge creation which 
involves the phases of knowledge inquiry, synthesis and products/tools.  The action 
cycle on the perimeter represents the phases related to knowledge application.  
These are: identify the problem/identify review, select knowledge, adapt knowledge 
to local context, assess barriers to knowledge use, select, tailor and implement 
interventions, monitor knowledge use, evaluate outcomes and sustain knowledge 
use.  It depicts movement and flexibility within the framework by using double sided 
arrows.  While appearing linear, in reality the knowledge translation process is 
complex and each phase can inform other phases.  This can happen sequentially or 
simultaneously, as the boundaries between knowledge creation and knowledge 
application are fluid and permeable (Graham & Tetroe, 2009).   
Knowledge Creation 
As knowledge moves through the funnel, it becomes more refined and useful as it is 
tailored to meet the needs of the end-users of the knowledge (Brouwers, Stacey, & 
O'Connor, 2010).  The knowledge creation funnel is divided into three interrelated 
parts.  Knowledge inquiry relates to the completion of primary research (Straus, 
Tetroe, & Graham, 2009).  It is also known as first-generation knowledge which is 
derived from primary studies, for example the results of a randomised control trial 
(Brouwers, et al., 2010).  Synthesis is about focusing on whether there is a reliable 
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and valid base of evidence that exists (Brouwers, et al., 2010).  The findings that 
exist on any given topic are brought together and the quality of the evidence is 
considered (Straus, Tetroe, & Graham, 2009).  This involves looking at the evidence 
as a whole, rather than relying on individual studies.  This synthesis of evidence is 
also known as second-generation knowledge and provides the basis for tools such as 
decision aids, guidelines and policies (Brouwers, et al., 2010).  The development of 
a product or tool is known as third-generation knowledge (Brouwers, et al., 2010).  
This presents the knowledge in a user-friendly format for stakeholders, which can 
help facilitate the uptake of knowledge (Graham, et al., 2006).  To increase the 
likelihood of implementation, ideally, a multi-disciplinary group would be engaged 
with the development and endorsement of the tool (Brouwers, et al., 2010).  
Strategies then have to be put into place to ensure that this knowledge passes 
through each of the phases of the action cycle.     
Knowledge Application (Action Cycle) 
The cyclical part of the framework represents the phases by which knowledge is 
implemented (Straus, 2009).  This requires a proactive effort to encourage the use of 
knowledge at the decision-making level (Harrison, Legare, Graham, & Fervers, 
2010).  The action cycle is divided into seven interrelated parts (Figure 4 p. 29) 
which are discussed next.   
 
The action cycle begins by first identifying a problem that requires addressing 
(Graham, et al., 2006).  Knowledge or research relevant to that problem is then 
selected (Doran, 2010) and the local and social context are considered (Kitson & 
Phil, 2009).  Customising knowledge to a particular organisation can improve 
compliance, especially when there is active involvement of the end-users (Harrison, 
et al., 2010).  Part of this process includes identifying people who can help, support 
or facilitate this change (Graham, et al., 2006).  The uptake of evidence and adapting 
to change is closely associated with assessing barriers to knowledge uptake 
(Harrison, et al., 2010).  When barriers have been identified, then specific 
interventions should be linked to each barrier and tailored in a way to overcome 
them (Wensing, Bosch, & Grol, 2010).  Examples of different types of interventions 
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are: professional interventions (educational programmes, decision support tools), 
passive educational interventions (guidelines, conferences), active educational 
interventions (websites for self-study), organisational interventions (enhanced 
teamwork, revision of roles), patient-directed interventions and financial 
interventions.  But there is a lack of evidence around which is the most effective 
type to use (Wensing, et al., 2010).  However what is known is that any intervention 
that employs only one technique is unlikely to produce a change in performance 
(Davis & Davis, 2010).  Monitoring the uptake of knowledge is another important 
aspect of the application process.   
 
The extent to which knowledge is being used needs to be measured (Straus et al., 
2010).  Strategies employed to measure knowledge uptake may vary according to 
the group being monitored.  For example, when assessing policy-makers you may 
use interviews and document analysis.  When assessing physicians, you may use 
clinical databases, or when assessing patients, surveys may be used (Straus, et al., 
2010).  When the degree of knowledge use is found to be less than expected, it may 
be necessary to reassess the barriers to knowledge use (Straus, et al., 2010).  It is 
also important to measure whether the new knowledge is actually making a 
difference and having the intended impact.  Evaluating outcomes involves 
determining whether the knowledge being applied is actually improving health 
outcomes and whether the effort required for implementation is worthwhile 
(Graham, et al., 2006).  Monitoring outcomes may also result in finding unintended 
consequences of a new intervention (Straus, et al., 2010).  Ideally, outcomes should 
be measured at the patient level.  But determining outcomes at the patient level can 
be a prohibitively expensive exercise to undertake (Straus, et al., 2010).  This often 
means outcomes are not evaluated properly and in turn there is no sustaining of 
knowledge use.  Sustainability is “the degree to which an innovation continues to be 
used after initial efforts to secure adoption is completed” (Rogers, 2005, p. 429).  
Sustainability is also “when new ways of working and improved outcomes become 
the norm” (Maher & Evans, n.d, p. 2).  The sustainability phase is supposed to set in 
motion a feedback loop that cycles itself through the action phases of the framework 
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(Graham, et al., 2006).  Little has been written about this aspect of the KTA 
framework even though it is an integral part of the knowledge translation process.  
The application cycle is intended to be a continuous ongoing process and this is 
achieved by sustaining knowledge use.  
 
Why use this framework? 
A framework organises a set of coherent ideas, so they can be more easily 
communicated to others (Doran, 2010).  It is helpful for health professionals to learn 
about theoretical frameworks so they can understand how to increase the uptake of 
knowledge and influence change in their practice setting (Graham, et al., 2006).  
Closing the research-practice gap is a complex endeavour and a conceptual 
framework can help with understanding this process better (Graham & Tetroe, 
2007).  When using any framework, documenting your experiences can enhance the 
understanding of others wanting to use it (Graham & Tetroe, 2007).  So it is 
acceptable for researchers to comment on the particular contribution a framework 
makes. 
 
Knowledge translation is a field in its infancy with most commentary in the form of 
opinion pieces and anecdotal reports, with limited formal evaluation having been 
done (Mitton, Adair, McKenzie, Patten, & Perry, 2007).  It has been acknowledged 
by its authors that the KTA framework “has been widely cited, but has not, as yet, 
been tested empirically” (Graham & Tetroe, 2010, p. 207).  However, ten of the 
theories used in designing the framework had been empirically tested.  The authors 
were “unaware of studies that have been specifically designed to evaluate the KTA 
framework” (Graham & Tetroe, 2010, p. 216).  There are only a few examples in the 
literature where the framework has been used in strategy or project development.  In 
one example the framework was used as a model for the development of a 
mentorship strategy (Straus, Graham, Taylor, & Lockyer, 2008).  In another example 
the framework was used to design a project on preventing delirium after a hip 
fracture (Straus & Holroyd-Leduc, 2008).  More studies evaluating the framework 
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are needed so “future iterations of the KTA cycle will be informed by feedback from 
the researchers and knowledge-users who are trying to apply it” (Graham & Tetroe, 
2010, p. 207).   
 
This thesis is timely and relevant, as there is a need for more research to be 
completed around evaluating knowledge translation processes.  This study was not 
specifically designed to evaluate the effectiveness of the KTA framework.  The main 
focus of this research was to evaluate how CBWC were implemented at one NZ 
DHB and the impact of utilising CBWC.  Early on it became apparent that the 
implementation process was complex.  To be able to interpret what happened and 
describe the implementation processes in a meaningful way the KTA framework 
was selected retrospectively as a research tool to organise the data collected.  By 
using the framework in this way I was then able to comment on its usefulness when 
applied to the clinical practice issue of implementing CBWC.   
 
Summary 
Knowledge translation is about putting knowledge into action.  The process itself is 
complex and using a framework can aid in understanding the dynamics involved.  
The KTA framework conceptualises knowledge translation theory by depicting the 
ideal phases that should occur.  It illustrates that implementing change and 
incorporating new evidence is an ongoing process.  The ultimate purpose of 
knowledge translation is to improve health outcomes and service delivery.  This is 
measured by evaluating whether the knowledge is used as it was intended and 
whether it improves clinical outcomes.  This research study is about evaluating how 
the evidence behind CBWC was implemented at one NZ DHB and the outcomes 
resulting from this change in practice.  The following chapter describes the overall 
study design and methods used and provides the justification for why an evaluation 
research approach was chosen.  
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Chapter Four: Research Approach and Design 
Introduction  
The setting for this study is a maternity unit at one NZ DHB, which calculates a 
CBWC for every birth.  The DHB understood they were the only hospital in NZ 
using CBWC to identify SGA and LGA babies and their subsequent risk of 
hypoglycaemia.  The hospital provides secondary care maternity services for a large 
Maori birthing population and has 700 to 750 births per year.  Having previously 
worked at the DHB I was familiar with the maternity service structure.  I was aware 
the DHB had wanted to evaluate any outcomes since implementing CBWC, but 
hadn’t had the opportunity to do so.  This study was designed to answer this question 
and other questions concerning the implementation of CBWC at the DHB.  This 
chapter outlines the approach and design selected to answer the overall research 
question and objectives.  It provides the rationale for choosing this approach and 
describes the methods used to achieve this evaluation.  As well, it describes the 
systematic way in which the data was collected and analysed and discusses some of 
the ethical issues involved.   
 
Research approach and design  
This study uses a mixed method evaluation approach to answer the overall research 
question which was: 
 
How was the evidence behind the use of CBWC put into practice at one NZ DHB 
and what are the outcomes resulting from translating this knowledge into action? 
 
The first part of the research question asks; ‘How was the evidence behind the use of 
CBWC put into practice at one NZ DHB’.  To answer this required collecting 
qualitative data to gain the perspectives of individuals involved with implementing 
CBWC.  The second part of the question asks; ‘What are the outcomes resulting 
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from translating this knowledge into action’.  Answering this part would require the 
collection of quantitative data to evaluate outcomes resulting from this change in 
practice.   
 
Several objectives were developed by dissecting the research question into smaller 
parts.  Examining each part then contributed to answering the research question as a 
whole.  The objectives chosen to answer the overall research question were:  
 
• To identify and critique the evidence relating to the use of CBWC 
• To describe how CBWC were implemented at one NZ DHB 
• To evaluate the processes followed when utilising CBWC 
• To identify outcomes relating to babies identified as SGA or LGA using 
CBWC 
 
To adequately answer the objectives a variety of qualitative and quantitative 
methods were needed, so a mixed methods design was chosen.  The study was about 
evaluating the experiences of people and events that occurred as CBWC were 
implemented and the extent to which the processes of implementation were being 
followed correctly.  The study was also about evaluating some of the outcomes that 
resulted from introducing CBWC.  Therefore a process-outcome evaluation 
approach was chosen.   
 
Ethical approval to conduct this study was granted by the NZ Northern Y Regional 
Ethics Committee (see Appendix A).  Approval from the DHB where the research 
was conducted was also received.  Support was given from the Pouwhakahaere 
Hauora Maori (Maori Health Manager) and written approval was granted by the 
Chairman of the Clinical Board (see Appendix B).   
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The value in using a mixed method evaluation approach  
Evaluations are often conducted in the healthcare setting as they can help to improve 
programmes and assist decision making around whether a treatment or procedure 
should continue (Brophy, Snooks, & Griffiths, 2008).  Evaluations can highlight 
both the positive and negative impacts of an intervention, treatment, service or 
programme.  Even services which are implemented with the best possible intention, 
may actually result in people being worse off than when they started (Brophy, et al., 
2008).  The most effective healthcare programme would be one that is designed to 
have some kind of evaluation framework incorporated in it (Brophy, et al., 2008).  
This would allow for the programme to be evaluated at a later date.  Programmes 
need to be evaluated to see if it was implemented as planned and whether it is 
producing the intended outcomes.  Using mixed methods in an evaluation can help 
to “provide a more comprehensive view of the outcomes” (Datta, 2001, p. 33).  
Using both qualitative and quantitative methods is especially valuable when 
evaluating complex interactions (Campbell et al., 2000).   
 
Evaluation requirement of the study 
Evaluation can be considered a research methodology when the data is collected and 
analysed in a systematic way (Patton, 2002).  Evaluation research is usually 
investigator initiated and theory based, with the evaluation usually being the object 
of the study (Bickman, as cited in Patton, 2008).  This evaluation is being performed 
to fulfil the requirements for a Masters Thesis.  In this context, this evaluation can be 
considered research as it is being conducted in a systematic way, initiated by myself 
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A comprehensive definition of evaluation from the ‘Encyclopaedia of Evaluation’ 
states:  
 
Evaluation is an applied inquiry process for collecting and 
synthesizing evidence that culminates in conclusions about the 
state of affairs, value, merit, worth, significance, or quality of a 
program, product, person, policy, proposal, or plan.  
Conclusions made in evaluations encompass both an empirical 
aspect (that something is the case) and a normative aspect 
(judgment about the value of something).  It is the value feature 
that distinguishes evaluation from other types of inquiry. 
(Deborah Fournier, as cited in Mathison, 2005, p. 139)  
 
The empirical aspect of this evaluation is in illustrating how the evidence behind 
CBWC was implemented.  The normative aspect is in making a judgment about the 
value of CBWC.  Patton (2008) adds that by evaluating a programme, you can make 
judgments and develop an increased understanding of a programme.  In simple 
terms, the way evaluation differs from other types of inquiry is that it measures the 
value of something.  This simplistic definition demonstrates the broad scope of 
evaluation.  This provides the researcher with the ability to look at almost anything 
in a meaningful way by using appropriately selected methods.  As a result, 
evaluations are often categorised by type or focus. 
Evaluation types or focus 
Patton (2008) provided a table which lists 79 different evaluation focuses or types 
and explains that the list doesn’t exhaust all the possibilities.  More than one type 
may be used within an evaluation or others may be implemented over time as the 
focus or defining question of the evaluation changes.  The three most common types 
of evaluation are: outcome evaluation, process evaluation and summative evaluation 
(Table 3).  The type chosen will depend on the defining research question or 
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Table 3.  Ways of focusing Evaluations 
Focus or Type of Evaluation Defining Question or Approach 
Outcomes evaluation To what extent are desired client/participant 
outcomes being attained?  What are the effects 
of the programme on clients or participants? 
  
Process evaluation Evaluating the activities and events that occur as 
part of implementation:  What do participants 
experience in the programme?  What are the 
strengths and weaknesses of day-to-day 
operations?  How can these processes be 
improved? 
  
Summative evaluation Should the programme be continued?  If so, at 
what level?  What is the overall merit and worth 
of the programme? 
Adapted from (Patton, 2008, p. 300). 
 
An outcome evaluation is usually conducted retrospectively on established 
programmes, so sufficient time has lapsed for the program to cause an effect (Owen, 
2006).  A process evaluation “looks at how the intervention is formed or how the 
processes of the intervention come together, and focuses on the ways that a 
programme or intervention is working” (Brophy, et al., 2008, p. 27).  Sometimes 
these two types are combined to then become a process-outcome evaluation.  This 
evaluation will measure the degree of implementation, as well as determining 
outcomes.  This is often necessary because the outcomes might be better explained 
once the extent to which the programme has been implemented is understood 
(Owen, 2006).   
Applying a mixed method evaluation approach  
Performing a mixed methods process-outcome evaluation is appropriate as both 
qualitative and quantitative data is required to answer the research question and 
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Patton (2002) lists four ways that qualitative inquiry is appropriate when trying to 
understand the dynamics of how a programme or organisation works: 
 
1) depicting process requires detailed descriptions for how people 
engage with each other 
2) the experience of process typically varies for different people so 
their experiences need to be captured in their own words  
3) process is fluid and dynamic so it can’t be fairly summarized on 
a single rating scale at one point in time 
4) participants’ perceptions are a key process consideration (p. 
159)   
 
Understanding and describing these dynamics can help you decide what elements 
may have contributed to the success or failure of the programme (Patton, 2002).  
Quantitative inquiry in evaluation is often used when “selecting measures for the 
intended programme outcomes and assessing the extent to which changes in the 
outcomes for the programme’s target population can be attributed to the 
programme” (Jennifer Greene & Gary Henry, as cited in Mathison, 2005, p. 348).  
To understand the processes involved with implementing CBWC at the DHB, a 
mixed method evaluation was required. 
 
Mixed methods research in evaluation has been defined as: 
 
… one that planfully juxtaposes or combines methods of different 
types (qualitative and quantitative) to provide a more elaborated 
understanding of the phenomenon of interest (including its 
context) and, as well, to gain greater confidence in the 
conclusions generated by the evaluation study. (Valerie Caracelli 
as cited in R. Johnson, Onwuegbuzie, & Turner, 2007, p. 119) 
 
By using different methods to gather different kinds of data, the validity of the study 
increases through the use of triangulation.  Triangulation increases certainty in the 
results by using methods which can cancel out each other’s limitations (Datta, 2001).  
Triangulation in evaluation can also enhance “the validity or credibility of 
evaluation findings through results from the different methods that converge and 
agree one with the other” (Jennifer Greene, as cited in Mathison, 2005, p. 255).  
Mixed methods is commonly used in evaluation as it can help us to better understand 
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“complex, multifaceted, real-world social phenomena” (Jennifer Greene, as cited in 
Mathison, 2005, p. 255).  Using both qualitative and quantitative methods is 
particularly helpful when evaluating complex knowledge translation interactions 
(Straus, et al., 2010).   
 
In determining the best way to use mixed methods to evaluate the implementation 
process, I realised I needed to support my description of events from a theoretical 
perspective.  The literature was examined to determine what theories might be useful 
to help answer my research question (Creswell, 2009).  I explored knowledge 
translation theory, which is about putting the action back into evidence based 
practice.  I examined the knowledge-to-action (KTA) framework which described 
the ideal phases required for knowledge translation to occur.  I decided to apply the 
KTA framework retrospectively as a research tool to help me describe what 
happened in a meaningful way.   
Using the KTA framework as a research tool 
The KTA framework was used to provide a theoretical rationale to explain how each 
implementation process was interrelated.  Using a framework to evaluate an 
implementation process provides a holistic account of what happened by showing 
multiple perspectives and identifying the various factors involved (Creswell, 2009).  
The funnel shaped section of the framework relates to knowledge creation.  These 
steps occurred as a result of the research that went into the development of the 
CBWC calculator.  This is described in Chapter Two which discusses the evidence 
supporting the use of CBWC.  The circular part of the framework relates to 
knowledge application.  In learning more about how the framework depicts the 
knowledge translation process, the action cycle seemed to naturally divide itself into 
two parts (Figure 5).  The first four headings of the action cycle (shaded green) 
related to the phases involved with the actual implementation process.  This part 
would be best described using mainly qualitative data.  The last three headings 
(shaded red) were about measuring the extent of implementation.  This part would 
be best explained using mainly quantitative data, but qualitative data could also be 
used to further validate the quantitative findings.  
  42 
 
 
                  
Figure 5.   The ‘coloured’ knowledge-to-action framework (Straus, Tetroe, 
& Graham, 2009, p. 167) 
 
Retrospectively applying the KTA framework to a clinical practice issue provided an 
opportunity to comment on the usefulness of the framework in this setting.  An 
additional research objective was then added to the previous objectives.  This 
objective did not aid in answering the overall research question, but provided insight 
into the useability of the KTA framework which was: 
 
• To evaluate the usefulness of the knowledge-to-action framework when 
applied to a clinical practice issue 
 
The KTA framework provided a template to be overlayed on top of what happened 
at the DHB, which then described the implementation process in an organised way.  
The methods selected provided the data embedded within the framework, which 
related the knowledge translation story.   
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Methods used to achieve this evaluation 
The purpose of an evaluation influences the design and methods chosen.  It is 
important that the methods chosen for data collection and analysis are the ones 
which will provide the best answers to the questions (Owen, 2006).  The resources 
available also need to be considered as you will be constrained by time, finances and 
expertise (Brophy, et al., 2008).  This relates to considering the rigour and feasibility 
of the evaluation.  Rigour involves making the evaluation strategy explicit and using 
valid methods.  Feasibility relates to keeping the evaluation strategy realistic and 
appropriate within the setting (Straus, et al., 2010).  This was small scale research 
project conducted to fulfill the requirements for a Masters Thesis, which limited the 
size and scope of the research.       
 
Interviews, focus groups, a clinical audit and document analysis were the methods 
chosen to answer the objectives and overall research question.  They were conducted 
in this order as the data collected from each method informed the next method used.  
Considering the relationships between the types of data collected influences the 
order and combination of methods (Saks & Allsop, 2008).  By performing the audit 
after the interviews and focus groups, the quantitative data did not influence how the 
qualitative data was collected.  This ensured stakeholder perceptions of their 
experiences could be compared with what was really happening in practice.   
1) Interviews 
Interviews were chosen to gain insight from individuals in management positions as 
to why and how CBWC were implemented at the DHB.   
 
Size and method of sample 
In having some knowledge of the maternity service structure at the DHB, I identified 
who I believed were five key people to interview.  These were the; Midwifery 
Educator, Maternity Unit Manager, Neonatal Quality Coordinator, Clinical Director 
of Women’s Health and Clinical Director of Child Health.  Letters of information 
(Appendix C) and consent forms (Appendix D) were mailed, inviting them to be 
  44 
 
interviewed.  I did not receive any response when trying to contact the Clinical 
Director of Women’s Health.  The Midwifery Educator informed me that the 
Clinical Director of Women’s Health was difficult to contact and was not really 
involved with implementing CBWC.  Instead she suggested interviewing a particular 
midwife who had been vocal about the changes.  This midwife was contacted to be 
interviewed instead.  An interview with the Clinical Director of Child Health was 
also not achieved after several requests to do so.  In the end, four interviews were 
completed. 
 
Method of obtaining data 
The Midwifery Educator was interviewed first, as she was the person most familiar 
with the implementation process.  This interview took the longest, but provided the 
greatest insight.  Next the Maternity Unit Manager, midwife and Neonatal Quality 
Coordinator were interviewed as they were available.  The interviews lasted between 
30 to 75 minutes and were recorded.   An interview schedule of basic questions was 
used (Appendix E).  Each interview informed subsequent interviews and specific 
questions were formulated relating to that individual’s role in the process.  The 
interviews also helped to refine the focus group questions.  I felt the interviews were 
successful as I was provided with the information needed to help answer the relevant 
research objectives.  Each interviewee was open and forthcoming with their 
responses and some came prepared with documentation to validate what they 
remembered.  Each participant expressed that they looked forward to hearing the 
results of the research.  Interviewees were given a gift voucher as a thank you for 
their participation.   
 
An interview is a “conversation with a purpose”, where specific topics are discussed 
in-depth (Hennink, Hutter, & Bailey, 2011, p. 109).  One-to-one semi-structured 
interviews are the most common qualitative method employed and is known as the 
‘gold standard’ approach (Barbour, 2008). They are often “used when seeking 
information on individual, personal experiences from people about a specific issue 
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or topic” (Hennink, et al., 2011, p. 109).  Semi-structured interviews were used as 
key people were known to be involved with the implementation of CBWC.   
 
Ethical considerations 
The rights of participants were considered by giving letters of information which 
fully disclosed what the study involved and emphasised voluntary participation.  It 
was important to maintain a balance between attempting to commit people to being 
part of the research and allowing people the right to decline to participate.  
Confidentiality forms were signed before the interviews commenced.   
 
Anonymity was maintained by not naming the DHB in the research.  For this reason 
demographics describing the setting are intentionally broad, including non-specific 
ethnicity statistics.  NZ is a small country and the DHB may have been identifiable if 
these statistics were used, as well as the interviewees.  Interviewees were aware they 
may be identified by their job title, but that they would not be individually named. 
 
Ethical consideration was needed in considering my personal reflexivity as a 
researcher.  This involved acknowledging and examining my own characteristics, 
biases and insights and how they might influence the participants, the evaluation 
process and the findings (David Williams, as cited in Mathison, 2005).  I was known 
by all the participants and this could have potentially indicated a conflict of interest 
and had an impact on the findings.  But I felt this wasn’t a hindrance as participants 
willingly shared information with me, as a rapport was already established.  I wasn’t 
working at the maternity unit at the time CBWC were implemented so I was 
unaware of the events that took place.   
2) Focus Groups 
Focus groups were chosen to gain an understanding of the end users perspective of 
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Size and method of sample 
Two focus groups were chosen as there were two distinct end user groups involved 
with calculating the CBWC and using it in practice.  One focus group was for LMCs 
(lead maternity caregivers).  These were self-employed community midwives that 
provided primary antenatal, labour, birth and postnatal care services.  Another focus 
group was for core staff (midwives and/or nurses) employed by the hospital who 
provided secondary care services for women and their babies.  Letters of information 
(Appendix F) and consent forms (Appendix G) were placed in the mail trays of all 
LMCs and core staff in the staffroom.  Posters (Appendix H) advertising the focus 
groups were pinned in the office and staffroom.  Reminders were emailed and texted 
to potential participants and some verbal RSVPs were received, but it was unknown 
how many would attend on the actual days. 
 
Method of obtaining data 
The focus group was moderated by myself and a brief question guide was used 
(Appendices I and J) which provided an unstructured approach.  In this way the 
discussion was facilitated rather than directed.  The order of focus groups was 
important.  The LMC focus group was held first and five from a possible eight 
LMCs attended.  A week later the core staff focus group met and six people 
attended.  The core staff focus group was held last as they are the ones who provide 
the ongoing management for babies identified as SGA or LGA by CBWC.  The 
focus groups lasted 45 and 60 mins and were recorded.  Within each group no one 
person dominated.  Participants appeared to be comfortable with expressing their 
opinions, which lead to some enthusiastic and open discussions.  Everyone was 
supportive of the research and looked forward to learning of the findings.  Lunch 
was provided as a thank you for their participation.   
 
A focus group gathers information from a selected small group of people through 
group discussion which aims to move from broader to more specific issues (Owen, 
2006).  This forum allows for the analysis of a complexity of views, rather than a 
single opinion (Saks & Allsop, 2008).  Participants are encouraged to talk to each 
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other rather than just answering the moderators questions (Smithson, 2008).  
Separate focus groups were held to facilitate an open discussion within each 
homogenous group, as the LMCs and core staff played different roles in the 
implementation process.   
 
Ethical considerations 
The same principles of confidentiality, anonymity, rights of participants and my 
reflexivity as a researcher were considered for those participating in the focus 
groups.  Participants were given letters of information and consent forms were 
signed before the focus groups commenced.  Quotes used from the focus groups 
were identified as LMC or CORE, rather than LMC 1, LMC 2 etc as it was possible 
that people within the DHB may be able to identify individuals from their comments 
made.  Quotes used from the individual midwife interviewed were included with the 
LMC quotes, as this person may have been identified by her colleagues if her 
comments were identified separately.  Within the focus groups while the moderator 
can guarantee confidentiality with keeping the focus group discussions private 
themselves, they cannot guarantee that participants will not discuss the group outside 
the meeting (Smithson, 2008).  Participants were reminded of the confidentiality 
agreement at the beginning, but this cannot be guaranteed outside the focus group. 
3) Audit 
An audit was chosen to evaluate if the correct processes were followed when 
calculating a CBWC and to identify outcomes for babies identified as SGA or LGA.   
 
Size and method of sample 
The maternity unit had approximately 700-750 births per year and 95% of these 
births were at term (≥37 weeks gestation).  An online sample size calculator was 
used (www.raosoft.com/samplesize.html) to determine the audit number, accepting a 
5% margin of error and a 95% confidence level.  The recommended sample size was 
249.  There were approximately 55 term births per month.  Auditing six months of 
births would include an estimated 330 term births, with additional babies eliminated 
once the final inclusion criteria was applied.  It was decided that births from January, 
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February, March 2009 would be audited, as well as births from November, 
December 2009 and January 2010.  January 2009 was chosen as the starting point 
because this would have allowed enough time from when CBWC were implemented 
for LMCs to routinely collect maternal height and weight.  January 2010 was chosen 
as the end point, so the audit was spread over a 12 month period.  This meant a 
comparison could be made to see whether the audit results changed over time.  
Births included in the audit were those ≥37 weeks gestation, but not including 
multiple pregnancies, stillbirths or congenital abnormalities, which was consistent 
with the methodology of other studies (McCowan, et al., 2004).  The final audit 
sample size was 303.   
 
Method of obtaining data 
The audit was conducted after the interviews and focus groups to prevent the 
findings influencing the interview and focus group process.  The audit tool 
(Appendix K) initially included the woman and baby’s NHI (National Health Index) 
number, date of birth and mother’s initials for ease of referencing.  This was later 
removed to anonymise the data for analysis.  A pilot audit of 10 births, which was 
included in the final data set, was performed to estimate the time needed and to see 
whether the tool collected the required information.  The birth register was used to 
fill in the tool as much as possible.  The clinical notes were then used to complete 
the audit tool.  Throughout this process the data was checked multiple times as it 
was entered on the audit tool spreadsheet.  Each tenth entry was also systematically 
checked as the tool was being completed.  The CBWC was computed using the 
centile calculator.  Each CBWC calculation was re-checked multiple times.  When 
the result was different from what had been recorded, or the result was borderline, or 
when a baby was identified as SGA or LGA, the result was checked several times 
again.  Any relevant details were included in the comments column.  Each CBWC 
was calculated individually rather than using the bulk calculator in order to simulate 
what happened in practice.   
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The audit took much longer than expected due to the time required to request notes, 
re-check results, investigate discrepancies and fatigue.  It was anticipated that only 
the maternal notes would need to be requested.  But partway through the audit 
period the layout of the maternal and infant clinical notes changed, which meant I 
also had to request the infant notes as well.  Instead of requesting over 300 notes I 
had to request more than 600 sets of clinical notes.  A significant error was also 
discovered near the end of the audit when I realised I was using version 5.15 of the 
centile calculator and the maternity unit was using version 5.13.  Version 5.15 was 
the most recent version which could be downloaded from www.gestation.net, but 
version 5.13 had not yet expired.  I contacted the Perinatal Institute who advised the 
difference between the versions was that BMI limits were removed (A. Francis, 
personal communication, May 5, 2010).  But this would most likely only result in 
small changes for very small or very large women (L. McCowan, personal 
communication, April 30, 2010).  I recalculated the CBWC for each birth using 
version 5.13.  In the majority of cases there was no change in the CBWC result.  
When the CBWC result did change, the difference was only small and there was no 
change in which babies were identified as SGA or LGA.  Recalculating every 
CBWC was necessary as one outcome being audited was whether the CBWC I 
calculated was the same as what had been recorded.  So it was essential that the 
same version of the calculator was being used.  
 
An audit is “any summary of clinical performance of health care over a specified 
period of time” (Sudsawad, 2007, p. 16).  An audit “compares actual practice to a 
standard of practice.  As a result of this comparison, any deficiencies in actual 
practice may be identified and rectified” (Ministry of Health, 2002, p. 7).  This is a 
relevant method to use when evaluating knowledge translation processes as audits 
can highlight implementation gaps and therefore priorities for knowledge 
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Ethical considerations 
When accessing the birthing register and clinical notes it was important that only the 
sections applicable to the research were examined.  The birthing register was 
accessed at the maternity unit only and was never taken off-site.  The clinical notes 
were accessed in the clinical records storage area and notes were never taken off-
site.  Once the audit tool was completed the data was then de-identified to protect 
anonymity.  The NHI numbers, date of birth and maternal initials were removed.  I 
was the only person to see the original raw data on the audit tool.  The quantitative 
data analysis was performed using de-identified data only and all reporting of results 
and tables used de-identified data. 
4) Document analysis 
Document analysis was chosen in addition to the previous methods, to provide 
additional information to support the data to be collected.  
 
Method of obtaining data 
Documentation was used to corroborate and verify what had been revealed through 
the interviews and focus groups.  For example, meeting minutes, emails, dated 
guideline drafts, guidelines and policies, letters and powerpoint presentations were 
used to verify dates and provide an accurate timeline of events.  These were all 
examples of secondary data which were collected and recorded at an earlier time (B. 
Johnson & Christensen, 2012) but was later used as part of this research.  The 
alternative was to rely solely on people’s memory recall of events, which likely 
would have resulted in inaccuracies in the data.  Documentation was provided to me 
by participants to provide evidence for their comments.  Other documentation was 
accessed in the maternity office which was freely available for all staff to read. 
 
Documentation review is useful when you want to find comprehensive, historical 
unbiased information that already exists (Mertens, 2010).  The documentation was 
able to give some of the “necessary background of the situation and insights into the 
dynamics of everyday functioning” (Mertens, 2010, p. 373).   
 
  51 
 
Ethical considerations 
Documentation given to me was kept confidential and anything electronic was 
stored on my password protected computer, with hard copies kept in a locked safe.  
Documentation of a more sensitive nature which was accessible in the maternity 
office was left in its original location and only notes were taken.  Only information 
relevant to the research, and in the timeframe being examined, was accessed. 
 
Other electronically stored data (audit results, interview and focus group transcripts) 
were kept on mine and my supervisor’s password protected computers and will be 
deleted after 10 years.  Copies of the audit results, original recordings of the 
interviews and focus groups and signed consent forms are stored in a locked safe and 
will also be destroyed after 10 years.   
 
Data analysis 
The KTA framework was chosen as a template to illustrate the knowledge 
translation process and the data collected was positioned within this framework.  
Using it in this way was appropriate because a conceptual framework can help to 
guide, interpret and understand an implementation process and provides an 
organised way to think, observe and interpret what happens (Graham & Tetroe, 
2009).  The headings in the framework provided the overall themes and thematic 
analysis of the qualitative data provided the subheadings.  The quantitative data was 
analysed using descriptive statistics. 
Qualitative data analysis 
Using the KTA framework provided a map of the ideal phases occurring during a 
knowledge translation process.  But this meant the data had to fit within the headings 
of the framework.  Both pre-determined codes [headings in the framework] and 
emerging codes [codes developed from the data] (Creswell, 2009) were used.  The 
analysis was deductive as it involved a process of coding the data then trying to fit it 
into a pre-existing coding frame (Braun & Clarke, 2006).  The data was interpreted 
and allowed to speak for itself but it was also structured so that the knowledge 
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translation process was described in a systematic way.  A basic generic form of 
qualitative data analysis was used which was to collect the data, analyse it for 
themes or perspectives and then report several themes (Creswell, 2009).   
 
Immediately after each interview and focus group, initial impressions were noted.  A 
table was constructed using the headings from the KTA framework to label each 
row.  The tapes were listened to and points were typed under the heading it seemed 
to best fit.  The process of transcribing tapes yourself is a good way to familiarise 
yourself with the data and develop a better understanding of the data (Braun & 
Clarke, 2006).  This allowed me to test whether my first impressions were supported 
by what was later heard on the tapes.  When a noteworthy statement was heard this 
was transcribed verbatim.  It is important to select compelling examples to illustrate 
the themes that emerge (Braun & Clarke, 2006).  Initially the table was also colour 
coded to identify who was speaking for ease of referencing, but the colour coding 
was later removed.   
 
This was a labourious and confusing process as it was sometimes difficult to decide 
which heading was most appropriate to use.  The process resulted in a large 
repetitive document.  This was re-read many times and headings were regrouped to 
combine similar themes, by cutting and pasting within the table.  Qualitative data 
analysis is a cyclical reflective process and is something you do with your data, 
rather than to your data (Carter, 2004).  Qualitative data analysis is also iterative in 
that it is something that you repeatedly return to and it can be a complex and messy 
process (Carter, 2004).   The coding was theory driven as there were specific pre-
determined headings that I wanted to use (Braun & Clarke, 2006).  One example of 
how codes emerged can be shown using the heading ‘Assess Barriers to Knowledge 
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‘Assess Barriers to Knowledge Use’ initial codes 
1) New knowledge 
2) Challenging guideline after it was signed off 
3) Intervention on bigger babies 
4) Accuracy of data 
5) Installing the calculator 
6) Mother/family resistant to change 
7) No ongoing use 
8) Not evidence-based 
9) ‘Normal’ weight babies identified as SGA or LGA 
10) Informing the mother 
11) Missing data 
12) Not following the guideline properly 
13) Imposing your own beliefs on others 
14) Time to accept it 
15) Resistant to change 
16) Fixing the results 
17) Heelpricks 
18) Interfering with breastfeeding 
19) Whose role is it? Is it primary or secondary care? 
20) Seeing the bigger picture 
 
When I was unable to condense the subheadings any further within the document, I 
printed them onto strips of paper.  The analysing process then became one of 
physically clustering and rearranging the subheadings over and over again.  This was 
done until five final subheadings emerged which were: 
 
‘Assess Barriers to Knowledge Use’ final codes 
1) Resistance to changing practice 
2) Using the CBWC calculator 
3) Increased intervention 
4) Following the guideline correctly 
5) Primary or secondary care responsibility?  
  
Halfway through the qualitative data analysis I realised I needed to use more direct 
quotes and I had to listen to the tapes again to transcribe more parts verbatim.  I had 
thought my original transcribing was completed at an appropriate level of detail 
(Braun & Clarke, 2006).  But it turned out to be a mistake to have not originally 
transcribed the tapes word for word, as this would have saved me a lot of time.   
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Quantitative data analysis 
After completing the audit, data had been collected for 318 births.  The data was 
checked and some births were removed as they did not fit the inclusion criteria, 
which was; births ≥37 weeks gestation, but not including multiple pregnancies, 
stillbirths or congenital abnormalities.  The decision was also made to remove any 
birth that was recorded in the register as BBA (born before arrival).  These were 
planned or unplanned homebirths where the mother and baby arrived at the hospital 
after the birth.  These births were excluded because there was variation around 
whether the mother and baby were admitted to the hospital and whether care was 
handed over to the core staff.  For example, one baby only had a few hours of 
transitional care in the NNU and then transferred home again.  The baby was never 
admitted to the hospital so the baby’s birth was incorrectly recorded in the register.  
Alternatively, another baby was admitted to the ward with its mother and care was 
handed over to the core staff.  Because some of these births were incorrectly 
recorded in the register and there was variation in how old the babies were when 
they were admitted, all BBA births were excluded.  The final audit number became 
303 births.     
 
Descriptive statistics relevant to the outcomes being evaluated were calculated and 
results were put into tables.  Descriptive statistics function to “describe or indicate 
several characteristics common to the entire sample … [and] summarise data on a 
single variable” (Mertens, 2010, p. 405).  Using the SPSS statistical package was 
beyond the scope of this study and the audit number would not have been large 
enough to be able to determine statistical significance in the results.  The 
quantitative findings were then placed within the appropriate heading in the KTA 
framework which was ‘Evaluate Outcomes’.    
 
Demonstrating validity and reliability 
Research aims to be objective by demonstrating reliability and validity.  Reliability 
is the extent to which a measurement procedure yields the same answer whenever it 
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is carried out and validity is the extent to which it gives the correct answer (Kirk & 
Miller, 1986).  Commonly, qualitative research relies more on measures allowing 
validity, whereas quantitative research relies on checks for reliability (Kirk & Miller, 
1986).  Using a mixed method approach which aims to combine “complementary 
strengths and nonoverlapping weaknesses of quantitative and qualitative research” is 
a contentious issue (Onwuegbuzie & Johnson, 2006, p. 48).  Combining methods to 
increase the overall validity of the research is a simplistic explanation for why it is 
used.  But it can be said that using a mixed methods design is “one criterion for 
increased validity in a research study with multiple purposes and questions” 
(Mertens, 2005, p. 301).  
 
Reliability is demonstrated by explicitly describing how the researcher collected and 
analysed the data (Kirk & Miller, 1986).  This was done in this chapter where the 
overall research design and methods used are described in detail.  Reliability is also 
about a “tendency toward consistency found in repeated measurements of the same 
phenomenon” (Carmines & Zeller, 1979, p. 12).  The reliability of the audit tool 
could be measured if someone else was to complete the audit and achieve the same 
results.  The calculator itself could be considered reliable in that when the same data 
is inputted it provides the same result.  As this is a small scale piece of research, I 
did not use statistical tests to determine reliability.   
 
Relating to qualitative data, validity is “a question of whether the researcher sees 
what he or she thinks he or she sees” (Kirk & Miller, 1986, p. 21).  Qualitative 
methods require a judgment to be made and will be influenced by an individual’s 
background knowledge and understanding.  Therefore, an element of nonvalidity 
will always be involved (Hammersley, 2008).  Some also argue that the validity of 
research is tested by the application of the knowledge that is produced (Hammersley, 
2008).  The application of this knowledge is valid in the current NZ maternity 
system as the use of CGC has been recommended for all pregnancies by the 
PMMRC.  The use of CBWC could be an extension of that recommendation.  
Generally, any measuring device can be considered valid if it does what it was 
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intended to do (Carmines & Zeller, 1979).  The audit tool and question guides could 
be considered valid in that they answered the objectives of the study and overall 
research question.   
 
Summary 
Evaluation was an appropriate research approach to select because of its 
characteristic broad scope.  This allowed a variety of methods to be employed to 
answer the study objectives, which in turn answered the overall research question.  
The use of a process-outcome evaluation meant that the process of implementation 
and the outcomes resulting from this change in practice could be examined.  A 
mixed methods design was needed to provide a better understanding of the complex 
processes involved, while also strengthening the validity of the research.  Using the 
KTA framework provided a way to discuss the findings within a theoretical context 
and ethical principles were adhered to throughout the research.  The following 
chapter describes in detail the results of the study using the qualitative and 
quantitative data collected.  This ‘knowledge translation story’ is told using the KTA 
framework as a template to outline the implementation process that took place.         
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Chapter Five: Results 
 
Introduction 
Making sense of the processes that occurred as CBWC were implemented at the 
DHB studied, was more complex than expected.  For this reason a knowledge 
translation framework was chosen to help organise the collected data in a 
meaningful way.  This chapter presents the results of the ‘knowledge translation 
story’ that occurred as the evidence behind CBWC was put into action at one NZ 
DHB.  The KTA framework is used as a template which provides the story outline 
and the data is positioned within the headings of the framework.  The knowledge 
creation funnel is not included as part of the results, as Chapter Two provides the 
background and evidence for using CBWC.  Therefore this chapter tells the story 
relating to the ‘action cycle’, which is about how the knowledge was implemented 
and put into action.  The first part of the story describes how CBWC were 
implemented using qualitative findings and the second part talks about measuring 
the extent of implementation using mainly quantitative findings.  Qualitative 
findings are also used to verify the outcomes of the audit. 
 
Part A: The implementation process, the story begins … 
The phases of the action cycle shaded green (Figure 5, p. 42) were involved with the 
actual implementation process.  These were; identify the problem/identify review, 
select knowledge, adapt knowledge to local context, assess barriers to knowledge 
use, select, tailor and implement interventions.  This part of the story is told from the 
perspective of the senior management involved with implementing CBWC, as well 
as the perspective of the staff and community midwives who were expected to abide 
by the appropriate guidelines and calculate a CBWC after every birth.  Practitioners 
were unfamiliar with CBWC and were challenged by having to use them as a 
method of identifying babies at risk of hypoglycaemia.  Many barriers existed to 
prevent individuals from applying the evidence into their practice.  The importance 
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of a champion was identified who maintained the momentum needed for CBWC to 
be put into practice.  She employed numerous interventions to progress the 
knowledge translation process beyond the knowledge creation stage.   
 
In this part of the story, ‘Assess barriers to knowledge use’ is discussed last, which 
is in a different order from the KTA framework.  The KTA framework was not used 
by the DHB implementing CBWC but was used by myself in making sense of the 
data.  So barriers were not identified before the implementation process began.  
Instead the barriers were identified by myself as part of the qualitative data analysis.  
The authors of the framework have explained that the phases do not have to be 
sequential (Graham & Tetroe, 2009) 
 
Extracts used to tell this story can be identified by the following key.   
 
Key for interview and focus group extracts: 
 
Midwifery Educator: Midwifery Educator/Quality Coordinator 
MM: Maternity Unit Manager 
NNU: Neonatal Unit Quality Coordinator 
LMC: Lead Maternity Caregiver (self-employed community midwives) and 
individual midwife interviewed  
CORE: Core staff midwife or core staff nurse 
 
1) Identify problem ↔ Identify, review, select knowledge 
At a small DHB, individuals often have multiple roles within the organisation that 
would be staffed by a number of employees at larger DHBs.  For example larger 
DHBs often have more than one Midwifery Educator whose sole role is to 
coordinate ongoing midwifery education needs.  The Midwifery Educator in the 
study had many responsibilities, including updating and formulating evidence based 
guidelines in her additional role as the Quality Coordinator and acting as the local 
Perinatal Maternal Mortality Review Committee (PMMRC) Coordinator.  In this 
role, she learned that the PMMRC were calculating CBWC for all perinatal deaths 
nationally, which was the first time she had heard of CBWC. 
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That’s what the PMMRC do and have done since July 2006.  So for 
any perinatal death they are collecting CBWC.  So I sort of looked at 
that, I didn’t really know what it was before then. (Midwifery 
Educator) 
 
At the time she was only able to locate sex-adjusted birthweight centile charts and 
decided to investigate what CBWC were.  She was introduced to GROW and began 
looking up the evidence around CGC and CBWC by Professor Jason Gardosi at the 
Perinatal Institute in the UK.  She then liaised with the National PMMRC 
Coordinator and Associate Professor Lesley McCowan, who did the NZ research 
around CBWC.  She learned that CBWC weren’t being used by hospitals and 
became excited that the DHB could be forward thinking by calculating a CBWC for 
every birth.  From examining the evidence, she felt that CGC and CBWC would be 
beneficial tools for the maternity unit to use and would help practitioners to better 
identify IUGR babies antenatally and SGA babies postnatally.  She felt as a DHB 
they could be providing better care for their ‘high risk’ birthing population and that 
babies were probably being missed.   
 
The next step was for her to introduce the evidence to other practitioners and 
convince them of the benefits.  She gave a presentation at a perinatal meeting in July 
2007 introducing the concepts around CGC and CBWC.  The majority of 
practitioners had never heard of CBWC, including midwives who had recently 
worked in the UK. 
 
There was talk about it but they hadn’t started using them when I 
left. I left June ’08 they were talking about this new system they were 
going to bring in but it hadn’t been implemented. (CORE) 
  
CGC were implemented first but it took time for LMCs to incorporate these into 
their practice.  CBWC were then included in the relevant guidelines, but could not 
be put into practice, as convincing IT technicians to download the calculator on the 
maternity unit computers proved difficult.   
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You can download this package onto your home computer but of 
course all the computers in the hospital have limitations put on to 
what you download, so I had to give a sort of a business case for 
getting those on to the computers. (Midwifery Educator) 
 
This obstacle was overcome when the findings of a HDC case relating to neonatal 
hypoglycaemia was released.  This acted as a catalyst to allow the Midwifery 
Educator to get CBWC fully implemented.  
 
The thing that really forged it ahead was the HDC case … that came 
up which actually really helped me to implement that and to give a 
reason and rationale for doing it. (Midwifery Educator) 
 
The HDC case released in Sept 2007 highlighted the problem of better identifying 
babies at risk of hypoglycaemia.  This case was brought to the attention of the CEO 
as a learning tool for DHBs.  The Clinical Director of Child Health was asked 
whether a similar scenario could happen at their hospital.  The Clinical Director and 
the Midwifery Educator made a joint presentation to the Clinical Board on what the 
maternity and neonatal unit had put in place to prevent a case such as this. 
 
We had to present a report on how we think it is unlikely to happen 
here or what we are putting in place and this was one of those 
things, the CBWC. (Midwifery Educator) 
 
Some felt the HDC findings had generated an exaggerated response from 
management. 
 
There’s this absolute fear.  Can I just say that it’s fear of litigation 
too.  There’s a lot of defensive practice as to why we implement 
things like this too.  Not on my shift, not in my hospital … I’ve heard 
it out of people’s mouths at the top management. (LMC) 
 
Once the tool was available on the computers, people were instructed on its use and 
which guidelines to follow.  It was at this point that the main debate about the issues 
began, as people were challenged by the reality of calculating and using CBWC in 
their practice. 
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[The Clinical Director of Child Health] would say look this is your 
guideline, it’s just signed off.  You had a chance to debate it and they 
didn’t actually when it was going through.  Only when it had gone 
through then afterwards they suddenly [did]. (Midwifery Educator) 
 
A UNICEF guidance document on hypoglycaemia was also published in December 
2007.  This initiated further debate and demonstrated that hypoglycaemia was a 
controversial topic worldwide and was not just a local issue.  Long before CBWC 
were introduced, the NNU Quality Coordinator vividly remembered having to write 
seven drafts of the original hypoglycaemia guideline.  Anything involving BSL was 
challenging to implement.  The UNICEF document was discussed at a perinatal 
meeting and became instrumental in adapting the hypoglycaemia guideline.  It 
provided the evidence for changing the timing and number of BSL and discussed 
how hypoglycaemia was less critical in larger babies.  This eased some of the 
concerns people had about increased intervention on babies.  A flowchart for the 
management of babies with hypoglycaemia (Appendix L) was also added to the 
completed guideline. 
 
The Midwifery Educator was the ‘champion’ that eventually saw CBWC put into 
action.  Many acknowledged her efforts, although they did not always agree with her 
methods of implementation.     
 
She did her best to bring it in because no one else had done all the 
ground work and good on her, because now we are streaks ahead … 
That’s because of her suaveness around keeping up with research … 
But the way it kind of happened is, this is it and just do it.  So you 
know it was kind of like, aye? (LMC) 
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When I first came and people were like we’ve always done it like 
that.  I said you must never say that to me.  Don’t say we have 
always done it like that ok, that’s your biggest mistake.  Because I 
don’t care what you have always done.  Why are you doing it?  Tell 
me why you are doing it and should we change it?  (Midwifery 
Educator) 
 
With the timely publication of the HDC findings and the UNICEF document the 
debate continued.  These documents provided the momentum the Midwifery 
Educator needed to fully implement CBWC.  During this time several interventions 
were also employed to help achieve this.     
2) Select, tailor, implement interventions 
Several interventions were routinely used when implementing new evidence in a 
guideline at the DHB.  But the Midwifery Educator noted in this case the process of 
implementation took longer than anticipated and required repeated interventions, 
which is outlined in Table 4.   
 
Table 4.  The implementation and intervention timeline 
Date Intervention 
2006 • ‘Management of hypoglycaemia of the newborn infant’ guideline updated by 
NNU quality coordinator.  Seven drafts required as the topic initiates a lot of 
debate and discussion. 
• New guideline ‘Blood glucose testing with heel stick blood sampling’ written by 
NNU quality coordinator. 
• Breastfeeding education provided to staff and LMCs. 
• Feeding charts (see Appendix M) developed for at risk babies. 
• Midwifery Educator learns about CBWC in her role as local PMMRC coordinator.  
She researches the work of Gardosi and McCowan and decides that CGC and 
CBWC are worthwhile tools to implement at the DHB. 
  
Feb 2007 • Amended ‘Management of well babies with low birth weights on the Maternity 
Unit’ guideline to include babies <10
th
 centile by CBWC. 
  
Mar 2007 • Business case completed by Midwifery Educator to have CGC and CBWC 
calculator downloaded. 
  
June 2007 • Guidelines, policies and procedures working group set up, which included 
community LMCs, to be chaired by Midwifery Educator. 
• NZAPEC (action on pre-eclampsia) study day organised by Midwifery Educator.  
Some midwives who attended remember McCowan discussing CGC and CBWC in 
her presentation. 
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July 2007 • Perinatal meeting presentation by Midwifery Educator on CGC and CBWC. 
  
Sept 2007 • HDC case released to DHB CEOs.  Midwifery Educator reads report and emails her 
comments to all relevant stakeholders.  CBWC already part of a guideline but she 
has not been able to get the tool downloaded by the IT department. 
  
Oct 2007 • CBWC calculator available on maternity computers. 
• Amended ‘Management of hypoglycaemia of the newborn infant’ guideline to 
include CBWC to identify SGA and LGA babies. 
• Ward staff meeting explaining the calculator was available and that a CBWC 
should be documented on the hand-over whiteboard and the infant summary 
sheet (see Appendix N), which was being updated.  
• Midwifery Educator confirms each staff member can access the calculator and 
provides individual training.   
  
Nov 2007 • HDC case presented and discussed at a perinatal meeting. 
  
Dec 2007 • Presentation by Midwifery Educator and Clinical Director of Child Health to the 
clinical board on how they would prevent a similar scenario to the HDC case from 
happening at the DHB. 
• UNICEF document ‘Guidance on the development of policies and guidelines for 
the prevention and management of hypoglycaemia of the newborn’ published. 
  
Jan 2008 • Midwifery Educator emails stakeholders about ongoing conflict around CBWC 
and managing babies at risk of hypoglycaemia. 
• Email communication with McCowan about some of the concerns being raised.   
• Review of ‘Management of hypoglycaemia of the newborn infant’ guideline, to 
incorporate UNICEF recommendations. 
  
Feb 2008 • Perinatal Meeting presentation reviewing key points from HDC case and UNICEF 
recommendations.  Heated debate about CBWC.  Draft of flow chart for 
‘Management of infants at risk of hypoglycaemia’ presented by NNU Quality 
Coordinator.   
• Email/letter send out to stake holders asking for further comments on flowchart.   
  
Mar 2008 • Flowchart (see Appendix L) finalised and included in guideline.  Includes changes 
in the timing and number of BSL and management of LGA babies. 
  
Mid 2008 • At least two incident reports written by the Clinical Director of Child Health when 
the guideline was not followed correctly. 
  
Nov 2008 • Letter sent to all LMCs by the Perinatal Committee Chairman (who was also the 
Clinical Director of Child Health), reminding them to complete CGC for all 
pregnant women. 
  
Dec 2008 • Amended ‘Management of well babies with low birth weights on the Maternity 
Unit’ guideline to include flowchart. 
  
Jan 2009 • Beginning date for clinical audit.  Commences 13 months after the CBWC 
calculator was first available and 10 months after the guideline includes the 
flowchart. 
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Each intervention allowed maternity practitioners to become more aware of the 
evidence and continued the debate and discussion. 
 
Two things that this is highlighting is that even with extensive 
consultation there can be a problem implementing the guideline.  But 





Main types of interventions 
 
a) Perinatal Meetings 
These are attended by senior obstetric, senior paediatric, maternity and NNU staff, 
LMCs and other relevant health practitioners.  It is a quality protected forum where 
recommendations are made to improve services.  Any major changes to policies are 
presented here for discussion.  Those implementing CBWC remember some of the 
discussions being quite challenging.   
 
I remember one specific perinatal meeting where it was a quite 
heated discussion around it.  I can’t remember whether that was 
after the guideline was out or during the implementation period? 
(MM)   
 
b) Guidelines 
Any guideline changes are emailed to maternity care providers and pinned on the 
notice board in the maternity office.  They were given one to three weeks to provide 
feedback on the changes.  But the Midwifery Educator rarely received any 
comments. 
 
I’d say look why don’t you feedback and give me something and they 
would say oh no it’s fine.  If you’ve written it, it’s fine and I’d say 
but that’s not good enough … You either agree or you don’t and if 
there’s things about it you are not happy with you must come back 
and say.  Or if you know something that I don’t, or whatever. 
(Midwifery Educator) 
 
  65 
 
Someone commented it was hard to give feedback on a guideline when you hadn’t 
used it in clinical practice before. 
 
Sometimes you have to actually use a protocol before you really sort 
of think, oh this is not there or something. (CORE) 
 
c) Flowchart 
The UNICEF document provided a sample flowchart for the management of 
breastfed babies at risk of hypoglycaemia.  This was adapted for use at the maternity 
unit.  Management wanted stakeholders to realise that the changes weren’t just about 
CBWC.  The changes were about improving the way they assessed babies at risk of 
hypoglycaemia.  The flowchart encouraged this, because it required practitioners to 
make judgments about the care they were providing. 
 
Nurses and midwives want a number so they can say that this baby is 
fine and I don’t need to worry about it and this baby isn’t fine and I 
need to worry about it.  People have real barriers with making 
intellectual evaluations of the care they are giving. (NNU) 
 
The timing of the first BSL was changed from being performed at one hour of age, 
to >2 hours of age, but before the second feed.  Two normal consecutive BSL were 
required instead of three.  BSL were no longer required for LGA babies if the 
mother had a negative diabetes screen in pregnancy.  These changes made the 
guideline less invasive, but required core staff to be more proactive in the care they 
provided. 
 
The interventions used were adapted for the local maternity service.  But the CBWC 
calculator tool itself doesn’t need to be locally adapted.  It is applicable across other 
DHBs as it is based on the main ethnic groups in a NZ birthing population. 
3) Adapt knowledge to local context 
The maternity unit was part of a secondary care hospital and provided services for 
women covering a large urban, semi-rural and remote rural area.  The DHB had a 
high Maori birthing population, compared to the national average of 21% (Ministry 
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of Health, 2010).  Stakeholders recognised that the DHB provided services for a 
high risk birthing population.   
 
We have the most socio-economically deprived area of NZ and we 
have a very high proportion of Maori and a very high proportion of 
them smoke or are obese.  So you know all those risk factors for 
IUGR babies.  We do have a lot of LBW babies.  We have a lot of 
prem babies and they are all because I believe, or most of them are 
due to our clientele and the smoking issue. (Midwifery Educator) 
 
It was also recognised there was an advantage to being a smaller hospital as staffing 
remained relatively consistent, which made implementing change somewhat easier. 
4) Assess barriers to knowledge use 
Standard processes and interventions were used when introducing CBWC, such as 
emailing the guideline changes and perinatal meeting presentations.  But 
practitioners were challenged more than usual by the evidence and the 
implementation process took longer than expected.  Practitioners had a number of 
issues with applying the knowledge and changing the way they practiced.    
 
a) Resistance to changing practice 
Practitioners recognised that the definitions used to identify SGA and LGA babies at 
the maternity unit were inadequate.   
 
This whole a birthweight of <2500 g you do this, or >4500 g you do 
this, I think it’s crap.  Because it just depends.  Because a 
birthweight of 2500 g at 34 weeks is actually really good but a 
birthweight of 2500 g at 41 weeks is really not good.  So I didn’t like 
that arbitrary cut-off line.  I thought it wasn’t relevant at all. 
(Midwifery Educator)    
 
In many ways people were already applying some of the underlying principles of 
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There was talk at the time that the birthweight centiles we were 
using were not effective working in a multi-ethnic hospital.  Really 
and truly you were talking about little Chinese ladies to bigger 
Jamaican ladies.  So really it just didn’t make any sense.  So I think 
we were sort of using them [CBWC] without using them … So I think 
the concept was there something wasn’t quite right. (CORE) 
 
But people would dismiss the CBWC result and regress to the old definition when 
challenged by a baby having what they considered to be a ‘normal’ birthweight who 
was identified as ‘at risk’. 
 
There was still a little bit of resistance to the 3 kg baby … and so 
that whole believing that those babies could still be at risk.  I think 
took a little while. (MM) 
 
Practitioners seemed less challenged by smaller babies being identified as SGA.  
They were more challenged by ‘big healthy babies’ having their BSLs monitored.  
They also found mothers were challenged by the changes as well.  They questioned 
why their baby needed to have BSL taken when previous babies of a similar 
birthweight had not been monitored for hypoglycaemia.  Some people also thought 
using CBWC was not breastfeeding friendly.  
 
If we have got a small baby you want to be keeping that baby skin to 
skin and as warm as possible and we have got the core midwife there 
saying you need to weigh the baby and see what the CBWC is.  You 
need to do a BSL. (LMC) 
 
But people began to change their practice when they experienced looking after a 
baby that was unable to maintain its BSL, who would not have been identified 
previously. 
 
Unless you have actually had them, you don’t really get it.  I think, 
because you just think oh for goodness sake they’re a normal size 
baby blah, blah.  But if you’ve been caught out I think that’s when it 
really rams home to you, whereas I haven’t.  So I’m probably a bit 
more blasé.  But if you have then it makes you think sh**. (LMC) 
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Eventually calculating a CBWC became a part of the culture of the maternity unit. 
 
It was incremental probably over a year … Now it’s just a routine 
thing. (Midwifery Educator) 
 
The majority of stakeholders now agree that CBWC are valuable.  Even those who 
opposed using them in the beginning have accepted calculating CBWC as good 
practice.   
 
b) Using the CBWC calculator 
CBWC were part of the guideline before it was accessible on the maternity unit 
computers.  But the delay in downloading of the calculator was rectified 
immediately once the issue was brought to the attention of the CEO.  Use of the 
calculator relies on the accurate collection and recording of data and accurate data 
entry.  Previously most LMCs were not routinely collecting pre-pregnancy weight 
and height, which are required to calculate a CBWC. 
 
The height and weight and BMI, again that’s another change that’s 
incremental.  Now 99% of women have them done … That took ages 
to get people to understand that … If you’ve got somebody with a 
BMI of over 30 you’ve actually got more risk factors in the 
pregnancy anyway. (Midwifery Educator) 
 
But there was variation in how this data was collected which caused some to 
question the accuracy of the CBWC result.   
 
Sometimes they don’t know their pre-pregnancy weight. (LMC)  
 
I just put the weight and say how many weeks they are. (LMC) 
 
I’ve had people turn up at 32 weeks and it’s not relevant. (LMC) 
 
When this information was missing sometimes the core staff would estimate a value 
or ask the woman what it was postnatally.   
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The other thing I’ve done is guesstimated you know.  You can put in 
she’s about this tall and about this weight and this is how much it 
would be and you think oh that’s ok. (Midwifery Educator) 
 
Everyone agreed the calculator was easy to use.  But because the data was entered 
manually people also commented that it was easy to make a mistake or manipulate 
results.  Both LMCs and core staff talked about seeing others ‘fix’ the CBWC result 
by changing a data value so a baby was no longer identified as SGA or LGA.   
 
Some of them are just like, nah I’m sure her heights this, oh no I think it’s, 
you know like sometimes people almost want to try and fix the results … they 
try to recheck and dates might be the one thing they try to, because if the 
baby can be slightly older or under it can make one point of difference. 
(LMC)  
 
But some LMCs and core staff disagreed with this practice.   
 
Sometimes the borderline babies with their weight are the ones that 
are crashing. (LMC) 
 
c) Increased intervention  
Using CBWC resulted in an increased number of babies identified as SGA or LGA, 
which meant more babies received heel pricks.  People weren’t concerned about the 
increase in their workload but were concerned about the increased invasiveness of 
the procedure.      
 
When it involves an invasive heel prick … that’s where people are 
reluctant to change their practice and I think that’s probably around 
if you don’t believe it yourself trying to convince the parents that us 
you know doing a heel prick on your baby is a good thing.  People 
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The guideline was modified accordingly to alleviate peoples’ concerns.   
 
We tweaked it at the end so the guideline became less invasive.  I 
think that’s probably what helped settle it.  It was around the timing 
of BSL and around how many ... I think that probably helped people. 
(MM) 
 
But despite this change people admitted performing more BSL than required 
because they were used to the old protocol.  But all agreed that performing a heel 
prick was better than a baby developing brain damage and the way this information 
was shared with mothers and their families was important.  
 
d) Following the guideline correctly  
Most of the resistance came after CBWC were included in the appropriate guidelines 
and people had forgotten about the education and consultation process that had 
occurred months prior.  
     
Often the people say they are fine with it and then the resistance 
comes after the guideline is signed off and the writers of the 
guidelines want feedback before it is put out. (Midwifery Educator) 
 
There was confusion over what people believed the guideline did and didn’t say.  
People were unaware that the baby’s temperature, respirations and heart rate were 
also meant to be recorded.  They were unaware that population BWC charts 
(Appendix O) were to be used when data was missing and a CBWC couldn’t be 
calculated.  There was confusion around monitoring LGA babies.  Many did not 
realise that BSL were not required if the mother had a negative diabetes screen in 
pregnancy.  Others questioned the accuracy of the polycose screening test and 
monitored the baby regardless of the polycose result. 
 
They have just changed the polycose thing so it’s not really 
applicable to pregnancy.  So they would have been raised on the old 
one, but because they have now moved the boundaries up with the 
new polycose it’s showing them as normal and it’s like, well which 
one do we go by?  Cause the new one isn’t really applicable in 
pregnancy. (CORE) 
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Incident reports were written by the Clinical Director of Child Health, when the 
guideline was not followed.   
 
There was a macrosomic baby that was on the 97th centile and the 
Paed ended up writing an incident report about that one because the 
protocol wasn’t followed correctly. (LMC)   
 
Some women also refused to have their babies monitored.   
 
Actually women still have the right to say no … and some women 
did, even after being informed they said no. (LMC)  
 
But midwives were cautioned about the information they were sharing with women.    
 
If you tell the mums what our guideline is and then they decline, then 
that’s ok.  It’s you as a professional making that decision to do it on 
behalf of them, that’s when it’s not I don’t believe ok … You’re a 
professional but actually it’s about the parents making the decision, 
not you … It’s around if you have that discussion with her then you 
must document it.  But if you didn’t have the discussion stop and 
think about is it your perception or is it the mother’s?  So get that 
clear in your head. (MM) 
 
There were also unwritten rules around how the CBWC was recorded. 
 
[It’s written in] three places.  One’s on the board, one’s on the 
neonate infant newborn summary and one’s in the register. 
(Midwifery Educator)  
 
Also missing from the guideline was instructions on whose role it was to calculate 
the CBWC.   
 
e) Primary or secondary care responsibility?   
There were differing views on whose responsibility it was to calculate the CBWC.  
One issue was that LMCs were not given computer logins so they couldn’t access 
the maternity unit computers.  But the calculator was usually available on any 
computer desktop which had been logged on. 
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I thought it was the job of the core midwife on handover to do the 
CBWC but somebody said to me recently, oh no it says in the 
guideline it’s the LMCs responsibility, and I thought oh?  I can’t 
remember putting that down.  I thought it was on handover, you 
know once the woman is handed over postnatally you need to do a 
CBWC. (Midwifery Educator)  
 
But some LMCs believed it was their responsibility and would calculate it 
themselves or ask someone to do it for them. 
   
I think I’d like to have it done before you leave though so you know 
and especially you can get some that kind of surprise you and have a 
low CBWC and you think whoa I wouldn’t have picked that one and 
so that baby is going to need obs.  So if you think about it, if you are 
leaving after the two hours that baby might be due another feed 
anyway or might be just about to go on the breast and so you are 
wanting to get that BSL done before that.  So I think it is a good idea 
to have it done before you leave. (LMC) 
 
The core staff believed the calculation should be part of the care provided by the 
LMC.   
 
That’s part of the first assessment … If they can do the baby check, 
the full baby check, then why can’t they just quickly sit down for two 
minutes and do a CBWC. (CORE) 
 
But the core staff felt that calculating the CBWC was largely left for them to 
complete.  Even though they felt it was inappropriate that they were the ones having 
to inform the women of the result. 
 
They are the ones [providing] primary care so if anything has got to 
change about that like a baby needing obs and BSL, then they should 
be the ones that inform the women of it.  Rather than a face that they 
have never met before coming in and going actually I’ve got to prick 
your baby’s heel every 3 hours. (CORE) 
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The core staff admitted that sometimes opportunities were missed, especially when 
the ward was busy.   
 
A couple of times it’s been a good few hours, you know six hours 
afterwards and you are like crap, oh what’s that CBWC and you 
work it out and it’s low and you are like oh no. (CORE) 
 
But if LMCs and core staff worked together this would not be an issue.    
 
When it’s quiet we can do it and get on with it.  But when we are 
running around like a lunatic and there’s only one midwife on shift 
… it would be helpful in that situation that when we are busy that 
they could just do it [the LMC] so that we wouldn’t have to worry 
about babies slipping through the net. (CORE) 
 
Most people agreed that regardless of who calculated it, the LMC should be aware 
of the CBWC result before handing over care of the baby to core staff.  
 
Part B: Measuring the extent of implementation, the story 
continues … 
 
The red shaded parts of the action cycle (Figure 5, p. 42) were about measuring the 
extent to which the CBWC had been implemented as intended and what outcomes 
had resulted from it.  No formal monitoring of outcomes had been done by the DHB 
itself.  But people believed after the initial challenges, that calculating CBWC had 
become part of the culture of the maternity unit.  They also believed using CBWC 
was making a difference in identifying babies at risk that previously would have 
been missed.  A clinical audit was conducted as part of this research, to measure the 
extent of implementation and evaluate outcomes.  Qualitative findings were also 
used to continue telling the story and validate the quantitative outcomes of the audit. 
5) Monitor knowledge use 
Nothing had been done by the DHB to monitor knowledge use, but stakeholders felt 
the knowledge of CBWC had initiated a proactive individualised management 
approach to neonatal hypoglycaemia.  Practitioners also began to notice how CBWC 
  74 
 
fit into the bigger picture of risk assessment and started making appropriate 
connections.   
 
a) Proactive management   
Using CBWC had resulted in a general increased awareness around identifying 
neonatal risk of hypoglycaemia.  The UNICEF document was instrumental in 
developing a flowchart which promoted a proactive approach to the management of 
hypoglycaemia.    
 
It’s actually promoting looking at that child in totality and not 
normalising the abnormal but not abnormalising the normal either.  
So if you’ve got a child that’s got a low CBWC, yes you are going to 
have to be proactive about the thermal management of that baby, 
feeding, about a multiplicity of things.  You might have to be really 
careful about early discharge … So I think it was making that 
intellectual shift to actually really looking at the baby instead of just 
wanting a number and yes that BSL is ok and I can ignore it.  So I 
think it’s an intellectual process and I think that has changed. 
(NNU) 
 
As a result, it appeared the number of babies admitted to the neonatal unit with 
hypoglycaemia had decreased.   
 
I haven’t seen one of those … for a year or so.  Where they come 
from the ward, they are really really sleepy looking, absolutely 
dreadful, unrecordable BSL and then you send it off to the lab and 
get a 0.6 or something.  We are not getting those now because I think 
we are more alert to those. (NNU) 
 
Staff were no longer waiting for the non-feeding baby to show signs of 
hypoglycaemia before deciding to intervene in some way.   
 
b) Individualising care 
Stakeholders felt that using CBWC was better than the old birthweight cut-off points 
as each baby was now considered individually. 
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Now it’s individualised, you are going by what is normal for that 
mum based upon her ethnicity, her parity, her height and weight, 
because we never put those factors in [before]. (LMC) 
 
Using CBWC picked up babies that were previously missed and it seemed to be an 
effective tool.   
 
There was one that was a 3 on the centile and it was admitted 
eventually for a week … It was 3.2 kg but on the 3rd centile. (LMC) 
 
The CBWC result become more than just a number and practitioners started to make 
connections with how it fit into the bigger picture of ‘risk’ for the mother and baby.  
 
c) Making connections  
People saw the value of CBWC in being about more than just the risk of 
hypoglycaemia.   
 
Really it is a screening tool and if anything it has helped me identify 
risk, risk behaviour and almost predicting outcomes. (LMC)   
 
A link was noticed with the importance of effective breastfeeding. 
 
I think it’s made people more aware … in general of the risk factors 
around babies feeding patterns and stuff and around the importance 
of actually seeing, making sure a baby has fed well.  Rather than just 
taking the mother’s word for it. (MM)     
 
It also increased awareness of how smoking in pregnancy was related to birthweight.     
 
Getting women to reduce smoking is the biggest thing we can do to 
reduce perinatal mortality ... and CBWC is something that makes up 
the whole picture. (Midwifery Educator) 
 
Many of the LMCs said since CBWC were implemented, they now routinely 
screened women for diabetes. 
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I think that because we’ve got the growth charts in pregnancy, the 
GROW package, we are doing a lot to try and educate women 
around diet … So I haven’t seen so many big babies over the 95th 
centile and since we have been screening all women for diabetes 
they are kind of picked up. (LMC)  
 
Connections were also made with a woman’s BMI and risk. 
 
I just had someone recently who is pregnant again and I did her’s 
and she’s obese and her baby came out SGA.  Her previous baby 
and I thought it wasn’t a huge baby, but a normal sized baby and 
quite interesting because of her weight it made her baby SGA. 
(LMC) 
 
People saw how CBWC linked with CGC charts completed in pregnancy.  When a 
baby was born with a low CBWC people started asking if the result had been 
unexpected and whether this was picked up antenatally.   
 
This baby had a CBWC of zero.  Did you not pick it up antenatally? 
What happened? (LMC) 
 
An LMC talked about one woman and how the CBWC result highlighted the other 
risk factors of her pregnancy. 
 
Smoking in pregnancy, alcohol involved … formula feeding … she 
kind of likes to co-sleep.  So huge risk factors around that baby 
being a SIDS risk … This baby was 2690g and see it was 42 weeks 
gestation and because of her size and her parity and stuff like that 
the baby wasn’t 2500 g but it was a zero CBWC.  So it’s been good 
in picking up babies like that. (LMC) 
 
After these experiences people became more vigilant in calculating the CBWC 
because they felt it identified babies who were previously missed.  The CBWC was 
seen as an effective screening tool and more than just a number. 
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6) Evaluate outcomes 
Stakeholders believed that the guideline was being followed correctly and that using 
CBWC was making a difference.  But no one had evaluated whether this was indeed 
true.    
 
Because nobody’s actually as far as I understand now looked at the 
research … after implementing it, to justify your actions, I suppose 
to see actually now yes it has improved outcomes for babies. (MM) 
 
Therefore, a clinical audit was performed to try to answer these questions and 
evaluate outcomes. 
 
Results of the clinical audit 
There were 303 births that fit the final inclusion criteria (Table 5).  The audit 
covered two three month periods, beginning and ending one year apart.  Births 
included in the audit were: ≥37 weeks gestation, no stillbirths, no congenital 
abnormalities, no multiple births and no BBA’s (born before arrival).  Data provided 
by the Maternity Unit Manager indicated the total number of births in 2009 was 701.  
Several outcomes were evaluated relating to following processes and which babies 
were identified by CBWC. 
 









Number of births fitting 
the inclusion criteria 
141 162 303 
 
 
a) Were processes followed correctly? 
Each CBWC was supposed to be recorded on the infant summary sheet (Appendix 
N) and in the birthing register.  According to the guideline, if a CBWC could not be 
calculated due to missing data, then sex-adjusted population birthweight centile 
charts (Appendix O) were to be used.  Whether this process was followed or not was 
audited (Table 6). 
  78 
 
 
The CBWC was recorded on the infant summary sheet and/or the birthing register 
76.2% of the time.  This improved over the audit period from 71.6% → 80.2%.  
Extrapolated for all births in 2009, potentially the CBWC would not have been 
recorded 167 times (23.8%). 
 
The maternal details were missing and no attempt was made to record a CBWC 
result, 3.6% of the time.  This improved over the audit period as the percentage 
decreased from 5%→2.5%.  For these 11 cases, the population BWC charts should 
have been used.  The maternal results were missing 22 times (7.3% (22/303), but for 
half of these a CBWC result was recorded.  So it was unknown how this result was 
calculated. 
 









Number of times the CBWC was 
recorded (on the infant summary 
sheet and/or the register) 
71.6% (101/141) 80.2% (130/162) 76.2% (231/303) 
    
CBWC recorded on infant summary 
sheet 
66% (93/141) 74.7% (121/162). 70.6% (214/303) 
    
CBWC recorded in birthing register 26.2% (37/141) 50% (81/162) 38.9% (118/303) 
    
Number of times maternal details 
were missing and no attempt was 
made to record a CBWC 
5% (7/141) 2.5% (4/162) 3.6% (11/303) 
 
In the 11 cases where no CBWC was recorded, I used the sex-adjusted population 
birthweight centile charts as the guideline indicated (Appendix N).  For all 11 cases 
the population BWC was within the normal range (between the 10th and 95th centile) 
selected by the DHB.   
 
Almost a quarter of the time there was no evidence of a CBWC having been 
recorded, but this didn’t necessarily mean that it wasn’t calculated.  It is possible that 
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the result was written on the handover whiteboard and was calculated appropriately.  
But this result is erased at the time of discharge.  When the CBWC is not recorded in 
the notes or birthing register, it gives the impression that it was not done.   
 
We write them in red up on the board, so it should be pretty obvious 
now whether it’s been done or not … Although I would have to say 
that probably they never or very rarely get filled on the green form 
[infant summary sheet] … The receptionist first thing in the morning 
when they come in they fill in the register. (MM) 
 
When staff were asked if they had ever used the population BWC charts the 





People didn’t realise that using them was part of the guideline and were unfamiliar 
with what the population BWC charts looked like and where they were located.     
 
The CBWC recorded and the CBWC calculated by myself were compared (Table 7).  
I was only able to compare a CBWC for 220 births.  27.4% of the time either some 
of the required data was missing, or a CBWC had not been recorded.  From these 
220 births, 62.7% of the time I calculated the same CBWC as the one that was 
recorded.  This improved over the audit period from 52% → 71.3%.  Extrapolated 
for all births in 2009, this means that potentially two people using the same data 
could calculate and record a different CBWC result for 261 births (37.3%).   
 
Calculating a different result 37.3% of the time appears high.  But in reality this only 
resulted in five instances where the clinical management of the baby would have 
changed.  For example, if I calculated a CBWC of 61 but 63 had been recorded, the 
baby would have still had a CBWC in the normal range.  Any baby with a CBWC 
<10 or >95 (if the mother did not have a negative diabetes screen in pregnancy) was 
required to have BSL monitoring.  Of these five cases, there appeared to be evidence 
of some of these results being purposely changed. 
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• For three cases I calculated a CBWC of 9, whereas a CBWC of 10 had been 
recorded.  The birthweights of these babies were 3180g, 3300g and 3100g.    
• In one case I calculated a CBWC of 96, whereas a CBWC of 95 had been 
recorded.  The birthweight of this baby was 4220g.   
• In one case I calculated a CBWC of 94 and 97 had been recorded.  The 
birthweight of this baby was 4540g.  It appeared a calculation error had been 
made.     
 
In the first four cases (1.8%(4/220)) discussed above, the results appear to have been 
purposely manipulated.   
 
It was not surprising to find evidence of results being manipulated as this practice 
had been disclosed in the interviews and focus groups.  But nobody admitted doing 
it themselves.   
 
Because I suppose of the different kind of perceptions staff have of 
the CBWC and doing BSLs they will say, oh look that baby looks 
perfectly alright for goodness sake it’s just under.  Lets say if we 
made it umm that she weighed this, you know take a couple kilos off 
or make her a cm taller, then the baby is in the normal range and 
they say now we don’t have to prick it’s foot. (LMC) 
 
This meant that four babies with what appeared to be ‘normal’ birthweights, were 
not identified as SGA or LGA.  Extrapolated for all births in 2009, potentially the 
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Number of births where I was able to 
calculate a CBWC and compare it 
with a recorded CBWC 
69.5% (98/141) 75.3% (122/162) 72.6% (220/303) 
    
Number of times where the CBWC I 
calculated was the same as the 
recorded CBWC 
52% (51/98) 71.3% (87/122) 62.7% (138/220) 
    
Number of times when the difference 
between the CBWC I calculated and 
the CBWC that was recorded could 
have been of clinical significance 
2% (2/98) 2.5% (3/122) 2.3% (5/220) 
 
 
b) The number of babies identified as SGA or LGA 
For the remaining outcomes, the audit sample will remain at 303 births.  A CBWC 
was calculated and recorded for 292 births, either by myself or the staff/LMCs.  
There were only 11 babies where no CBWC was able to be calculated or recorded.   
But the population BWC for all 11 babies were within the normal range.  Therefore 
the audit sample size remained at 303.  The babies identified as SGA or LGA were 
based on my calculations.  I believed my calculations were the most accurate, as I 
had re-checked my results multiple times. 
 
The number of babies identified as SGA or LGA using CBWC versus the cut-off 
weights of <2500 g and >4500 g, were compared (Table 8).  It shows that when 
using CBWC a larger number of babies were identified as SGA or LGA. 
 
There were 10.9% of babies identified as SGA using CBWC, compared with 3.6% 
of babies using the <2500 g cutoff.  There were 4.6% of babies identified as LGA 
using CBWC, compared with 3% of babies using the >4500 g cutoff.  Twenty-two 
(7.3%) more babies were identified as SGA using CBWC.  Extrapolated for all 
births in 2009, potentially 51 more babies would have been identified as SGA if 
CBWC were used.  Five (1.6%) more babies were identified as LGA using CBWC.  
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Extrapolated for all births in 2009, potentially 12 more babies would have been 
identified as LGA if CBWC were used.   
 









SGA babies by CBWC 9.9% (14/141) 12% (19/162) 10.9% (33/303) 
    
SGA babies by <2500 g  2.8% (4/141) 4.3% (7/162) 3.6% (11/303) 
    
Additional babies identified as SGA 
by CBWC vs <2500 g 
7.1% (10/141) 7.4% (12/162) 7.3% (22/303) 
    
LGA babies by CBWC 3.5% (5/141) 5.6% (9/162) 4.6% (14/303) 
    
LGA babies by >4500 g  2.1% (3/141) 3.7% (6/162) 3.0% (9/303) 
    
Additional babies identified as LGA 
by CBWC vs >4500 g  
1.4% (2/141) 1.9% (3/162) 1.6% (5/303) 
 
The number of babies who were identified as SGA by CBWC only (22), the number 
of SGA babies identified by <2500 g only (0) and the number of babies identified by 
both methods (11), are shown in Figure 6.  All babies <2500 g were still identified as 
SGA when using CBWC.  (Note: In Figure 6 the size of the circles and overlap is 
not drawn to scale).   
 
 
Figure 6.  The classification of SGA babies by CBWC vs <2500 g 
 




<2500 g only 
0 
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The data for the 22 babies that were identified as SGA by CBWC only is shown in 
Table 9.  A few notes about each of these babies are provided.  Among this list are 
examples of babies who potentially could have become unwell if their risk of 
hypoglycaemia was not recognised early.  For example, baby #20 was admitted to 
the NNU after recording a low BSL before and after its first breastfeed.  It continued 
to have low BSL results despite receiving intravenous (IV) Glucose and nasogastric 
tube (NGT) feeds.  The mother was Maori, obese and having her second baby.  In 
other examples babies required intervention in the form of breastfeeding assistance, 
hand expressing and expressed breast milk (EBM) and/or formula top ups to correct 
low BSLs.   
 
While more babies were identified, this doesn’t demonstrate whether fewer babies 
experienced morbidity or mortality relating to hypoglycaemia.  It also showed that 
even though CBWC were implemented, this doesn’t guarantee babies aren’t missed.  
For example, baby #15 was discharged one and a half hours after birth and no early 
discharge form was completed.  The baby’s birthweight was 3500g and no CBWC 
was recorded.  I calculated the CBWC as 9.  The clinical notes explained the baby 
had measured small in pregnancy until 37 weeks.  At 38 weeks there was a marked 
growth in fundal height.  At 39 weeks the fundal height again plotted small for 
gestation.  This was an example of a CBWC not being recorded and a SGA baby 
being discharged early.  In another example, baby #16 didn’t have a CBWC 
calculated until it was eight and a half hours old.  This baby was eventually admitted 
to the NNU with borderline BSLs and poor feeding.  These were both examples of 
missed opportunities where a baby potentially could have become very unwell. 
 
The average BMI for the mothers of these babies was 28.1 kg/m2 (range: 19 - 42.2 
kg/m2).  In NZ a BMI of 25-29.9 kg/m2 is considered overweight and a BMI ≥30 
kg/m2 is considered obese (C. T. R. U. Ministry of Health, 2009).  The average 
birthweight for these babies was 2915 g (range: 2500 – 3500 g), which is well above 
the previous cut-off point of 2500 g. 
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1 1.79 74 23.1 M 0 40+4 M 3180 9 Normal BSLs 
2 1.72 83 28.1 M 0 39+6 F 2920 7 Guideline not followed properly 
3 1.67 80 28.7 M 4 41+3 M 3120 2 Deceased one month after birth, no cause recorded 
4 1.70 55 19.0 E 0 40+2 F 2920 8 Written in mothers notes for no BSL, no reason given 
5 1.76 65 21.0 E 0 40+5 F 3000 6 Didn’t feed well, hand expressing, nipple shield, 3 normal BSL 
6 1.58 95.4 38.2 M 5 39+6 F 2780 4 Mother was gestational diabetic 
7 1.57 104 42.2 M 1 39+2 M 2660 3 Required formula after low BSL, then normal BSL 
8 1.72 99 33.5 M 0 40+6 F 2940 4 
Sleepy baby, BF and EBM given, multiple BSL taken, one result 2.3 
all others normal 
9 1.70 110 38.1 M 0 39+1 M 2915 7 
Apgar: 7, 7, lots of BF assistance, given formula and EBM top ups, 
one BSL 2.5, all others normal but <3, admitted Day 6 for jaundice 
10 1.64 56 20.8 M 0 40+4 M 2905 8 Apgar: 5, 8, first BSL 1.7, then normal 
11 1.65 65 23.9 E 0 42+1 M 3300 9 
Apgar: 7, 9, cold, large capput, jaundiced but normal result, BF 
assistance required 
12 1.55 65 27.1 M 0 41+1 F 2720 3 2 normal BSL 
13 1.67 63 22.7 M 0 40+2 F 2860 8 Multiple BSL taken as two results <2.6 
14 1.63 60 22.6 E 2 41 F 2960 5 BF well, normal BSL 
15 1.80 92 28.4 E 1 41 M 3500 9 Discharged at 1.5 hours old, no CBWC  recorded 
16 1.68 83 29.4 E 2 40+6 F 2980 3 
CBWC not done until 8.5 hours old, multiple BSL between 2.2-2.8 
with most <2.6, to NNU for poor feeding 
17 1.65 70 25.7 E 5 42 F 2680 0 Formula fed, chose not to BF 
18 1.65 91 33.4 M 3 40 F 2680 2 4 normal BSL 
19 ? 54 ? M 0 40+1 M 2500 0 Normal BSL 
20 1.56 73 30.2 M 1 41+1 F 2860 3 
Admitted to NNU, low BSL before and after the first breastfeed, 
BSLs of 1.5, 1.6, 1.3, borderline BSLs continued despite IV Glucose 
and NGT feeds 
21 1.71 65 22.2 M 4 38+1 M 2640 4 Took time to establish lactation, formula top ups after 1.4 BSL 
22 1.70 92.6 32.0 M 0 40+5 F 3100 9 
No BSL done, lots of BF assistance, unsettled baby, maternal 
request for formula 
Mean 1.67 77 28.1  1.3 40+4  2915 5  
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The number of babies identified as LGA by CBWC only (8), the number of babies 
identified by >4500 g only (3) and the number of babies identified by both methods 
(6) are shown in Figure 7.  Not all babies >4500 g were identified as LGA when 
using CBWC.  (Note: In Figure 7 the size of the circles and overlap is not drawn to 
scale).   
 
 
Figure 7.  The classification of LGA babies by CBWC vs >4500 g 
 
The data for the 8 babies that were identified as LGA by CBWC only are listed in 
Table 10.  There may appear to be a discrepancy with Table 8 (p.83) which showed 
five more babies were identified as LGA using CBWC vs 4500 g.  The difference of 
three babies is explained by the fact that not all babies who were >4500 g were 
identified as LGA when CBWC were used.  A few notes about each of these babies 
are provided.  From this list there is one example of a baby who could have 
potentially become unwell if their risk of hypoglycaemia was not recognised early.  
Baby #1 was admitted to the NNU with low BSL that didn’t improve with formula 
top ups and the baby’s birthweight was 4280g.  There were also some examples of 
BSL monitoring being performed incorrectly as the mother had a normal polycose.  
But in some of these examples the baby did have low BSL.  For example, baby #7 
and baby #8 had low BSL but their mothers had a normal polycose results.  This 
sample is small so no conclusive results could be drawn from these examples.   
 




>4500 g only 
3 
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While more babies were identified as LGA, this doesn’t demonstrate whether less 
babies experienced morbidity or mortality relating to hypoglycaemia since using 
CBWC.   
 
The average BMI for the mothers of these babies was 37.3 kg/m2 (range: 23 - 59.7 
kg/m2).  In NZ a BMI of 35-39.9 kg/m2 is considered to be moderately obese (C. T. 
R. U. Ministry of Health, 2009).  The average birthweight for these babies was 4123 
g (range: 3800 – 4440 g), which is well below the previous cut-off point of 4500 g. 
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1 1.7 150 51.9 M 1 37+5 M 4280 99 
Low BSL 1.9, 2.1, didn’t improve with formula top ups, admitted to 
NNU for BSL, top ups, jaundice, no maternal polycose 
2 1.64 109 40.5 M 3 38+5 M 4220 96 BSL not required 
3 1.4 65 33.2 M 1 38+6 M 3800 97 
Had one BSL 2.1, had to be woken for feeds, took time to establish 
BF, extra normal BSL done 
4 1.52 138 59.7 E 1 40 M 4420 97 Normal maternal polycose 
5 1.6 59 23.0 M 2 39 F 3860 96 Normal BSL 
6 1.72 84.5 28.6 E 2 37+1 M 3965 96 
Admitted to NNU from CS, CPAP, No CBWC recorded, BSL in NNU 
and immunoglobulin transfusion 
7 1.58 69.9 28.0 I 1 38+6 F 4000 99 
Six BSL done, two were 2.2, 2.5, but were stopped when it was 
noted the maternal polycose was normal 
8 1.68 94 33.3 E 1 39+3 F 4440 98 
Had low BSL 2.5, 1.5, several borderline results, not admitted to 
NNU, BF well, normal maternal polycose 
Mean 1.61 96.2 37.3  2 38+5  4123 97  
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c) Was the guideline followed correctly? 
The audit investigated whether BSL were initiated for babies that were identified 
as SGA (Table 11).  There were 29 babies recorded as being SGA.  In all but one 
instance BSL were initiated.  In this case the baby had a CBWC of 8 and a 
birthweight of 2920 g.  The CBWC had been recorded and underlined on the 
appropriate feed chart, but only temperature, respirations and heart rate 
observations were taken.  ‘No BSL taking’ had been written in the maternal 
notes, with no further explanation given.  This was possibly an example of a 
mother deciding against BSL monitoring, but observations were still performed 
to watch for symptoms of hypoglycaemia.   
 










BSL initiated for babies 
recorded as SGA 
92.3% (12/13) 100% (16/16) 96.6% (28/29) 
 
 
The guideline was not always followed correctly for babies identified as LGA 
(Table 12).  The guideline states that LGA babies (>95th centile) by CBWC 
where the “possibility of diabetes in pregnancy has not been excluded” need to 
have BSL monitoring.  Therefore, if the mother had a negative polycose or 
negative glucose tolerance test (GTT) in pregnancy, then BSL were not required.  
This was followed correctly 50% (7/14) of the time.  Seven babies had BSL done 
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1 Y N Y 
2 Unknown Y Y 
3 Y Y N 
4 Unknown Y Y 
5 Y N Y 
6 Y N Y 
7 Y Y N 
8 Y Y N 
9 Unknown Y Y 
10 Y Y N 
11 Unknown Y Y 
12 Y Y N 
13 Y Y N 
14 Y Y N 
   50% (7/14) 
    
This finding was not surprising as most staff and LMCs were unaware they were 
not required to perform BSL on LGA babies if the mother had a negative 
diabetes screen in pregnancy.   
 
d) Ethnicity and birthweight 
The ethnicities of the babies who were identified as SGA and LGA by CBWC 
are shown in Table 13.  It shows 75.8% of SGA babies were Maori and 57.1% of 
LGA babies were Maori.  The upper range for a SGA baby was 3500g.  The 
lower range for a LGA baby was 3800g.   
 
Table 13.  Ethnicity and birthweight of SGA and LGA babies identified by CBWC 
SGA babies by 
CBWC 
Total % 
LGA babies by 
CBWC 
Total % 
Maori 75.8% (25/33) Maori 57.1% (8/14) 
European 24.2% (8/33) European 35.7% (5/14) 
  Indian 7.1% (1/14) 
    
Birthweight range 1685g-3500g Birthweight range 3800g-4860g 
Birthweight mean 2680g Birthweight mean 4333g 
 
Although there are other ethnic groups which birthed at the maternity unit, the 
only ethnicities identified in the audit as SGA or LGA by CBWC were Maori, 
European and Indian.  Average birthing statistics for ethnic groups at the DHB 
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could not be listed as this would make the DHB identifiable, other than to say 
there was a high Maori birthing population. 
 
Measuring whether using CBWC improved outcomes for babies 
To measure whether outcomes had improved for babies, you would need to know 
the number of babies admitted to the NNU for hypoglycaemia.  You would need 
to know which of these babies had been identified using CBWC and compare 
this with the previous method of <2500 g and >4500 g.  There was insufficient 
data available to do this.  The 2009 NNU statistics indicated that 23 babies 
received treatment for hypoglycaemia.  Ten were admitted for hypoglycaemia, 
six were admitted with hypoglycaemia and hypothermia and seven received 
transitional care for hypoglycaemia.  But these numbers included the babies of 
diabetic mothers and babies who wouldn’t have met the study inclusion criteria.  
So there is no way to measure the effect on NNU admission rates unless the 
reasons for admission were specified.  The 2008 NNU statistics were also 
insufficient to be compared to the 2009 statistics.   
 
Babies identified as ‘at risk’ using CBWC received early intervention in the form 
of staff facilitating early, frequent and effective breastfeeds.  It would be difficult 
to know if these babies would have had normal BSL without this type of 
breastfeeding support.  The only evidence therefore that outcomes improved for 
babies since using CBWC is anecdotal.   
  
Those involved believed that using CBWC was making a difference because it 
appeared there weren’t any babies being admitted to the NNU with unexpected 
low BSL.  Practitioners felt that low BSL levels were now being corrected before 
a baby became compromised, through implementing a proactive management 
approach.  Over time using CBWC was reinforced as people experienced looking 
after ‘normal’ birthweight babies who weren’t able to maintain BSL despite 
receiving extra breastfeeding support and/or breast milk and formula top-ups.  
Some examples of babies who required extra intervention to maintain normal 
BSL, who previously would not have been identified were shown in Table 9 (p. 
85).  There is no way to determine if these differences in outcomes are 
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statistically significant, as the audit size would have been too small and the 
correct data wasn’t available.  But clinical significance could be argued if just 
one event such as the HDC case was prevented, as having a child with severe 
brain damage resulting from hypoglycaemia would be clinically significant for 
that family.   
7) Sustain knowledge use 
Nothing had been done by the DHB to sustain the use of the knowledge 
associated with CBWC.  But there was a general feeling that attitudes had 
changed and people were now happy to calculate CBWC.     
 
a) Common practice  
Stakeholders believed that calculating a CBWC for every birth had become 
routine practice on the maternity unit. 
 
How do you keep it going?  Well we haven’t really because 
everyone’s ok about it. (Midwifery Educator)   
 
b) New staff 
As part of their orientation, new staff are informed of the policies around 
calculating CBWC.   
 
As part of the orientation we give them the index of all the guidelines 
so that they know … On our checklist would be setting them up on 
the computer IT system and making sure that they’ve got CBWC as 
well. (MM) 
 
The CBWC is often an unfamiliar concept for new and locum staff, but it isn’t as 
difficult to convince one person to change their practice.   
 
Initially they were trying to convince a whole staff that this is new 
practice and we should do it.  Whereas now that all the staff are on 
board it’s such a culture of the ward, so it’s less of a big deal when 
one person comes in and it’s easier to say yes we do this and it’s in 
the guideline. (Midwifery Educator) 
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But when new staff questioned the use of CBWC, it required people to revisit the 
evidence.  
 
It’s great now that people just do it and it is just in practice and 
that’s why it’s just a bit tedious when a new person comes in.  But it 
keeps you on your toes if they question it you know.  You can’t just 
become complacent can you, you’ve got to revisit it. (Midwifery 
Educator)  
 
When a new Paediatrician started who was unfamiliar with CBWC, many felt his 
questions were undermining the previous work that had been done. 
 
He’s just come from somewhere that doesn’t do it, so he’s right at 
the very beginning of complete disbelief about the whole thing. 
(Midwifery Educator) 
 
I have since been informed that he is now convinced of the value of CBWC after 
experiencing their worth in clinical practice.  
 
c) Guideline reviews   
All guidelines are reviewed every two years or earlier if new evidence becomes 
available.  The new Paediatrician was invited to help review the guideline in an 
attempt to make him aware of the evidence.   
   
He has not bought into CBWC … and he’s just not familiar with it.  
I’ve given him the readings and what I’ve said to him is I think he 
needs to help me review the guideline in March [2010].  Because 
it’s really important that the paediatricians are fully on board with 
it because it is very undermining if they are not.  But the other 




The story of how CBWC were implemented at this DHB was more complex than 
anticipated.  So a knowledge translation framework was used to describe how 
this evidence was put into action.  The headings of the action cycle of the KTA 
framework were used to provide the outline for the story.  The knowledge 
translation story began with the Midwifery Educator enquiring about CBWC.  
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She then decided it was a valid tool to implement at the DHB, who provided 
services for a high risk birthing population.  She was instrumental in facilitating 
the various interventions required to implement CBWC.  She initially faced 
many challenges with implementing the knowledge, but with the release of the 
HDC findings and the UNICEF guidance document she was able to continue the 
momentum required to get CBWC fully implemented.  The opposition to CBWC 
reduced as people began to experience looking after babies with ‘normal’ 
birthweights who were unable to maintain their BSL, despite early intervention.  
Consequently, calculating a CBWC for every birth became common practice and 
people began to accept the CBWC result regardless of birthweight.  Although no 
formal evaluation of outcomes had occurred people felt using CBWC was 
making a difference by identifying ‘at risk’ babies who would have previously 
been missed.   
 
An audit was conducted to evaluate if processes were being followed correctly 
and if outcomes had improved.  The audit showed that although it was easy to 
make a mistake when calculating a CBWC, in most cases it did not make a 
clinical difference.  But this also meant it was possible to purposely change a 
result so a baby was not longer identified as SGA or LGA.  It showed that the 
CBWC was not always being recorded in the right places.  It showed that the 
guideline was not always followed correctly, especially in regards to the 
management of LGA babies.  But it was unknown whether using CBWC had 
actually reduced neonatal morbidity or mortality relating to hypoglycaemia at the 
DHB.  The correct data wasn’t available to measure this, which was the outcome 
people were most interested in.  It showed that using CBWC identifies more 
babies as SGA and LGA, with the majority of these being Maori, who are a high 
risk birthing group.  The following chapter discusses some of these key findings 
in further detail and comments on the research as a whole.   
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Chapter Six: Discussion 
Introduction 
While dissecting the complexities of the knowledge translation story a number of 
interesting results were discovered.  This chapter is divided into three sections 
and first discusses the more important findings relating to implementing and 
applying CBWC into practice.  Some of the practical issues of using the CBWC 
calculator are highlighted, as well as the barriers which stakeholders found most 
challenging to overcome.  Next, the knowledge translation process itself is 
discussed and the usefulness of applying the KTA framework to a clinical 
practice issue is explored.  Finally, the chapter will reflect on the research as a 
whole and the limitations and significance of the study and suggest 
recommendations and ideas for future research.   
 
Section A: The process of implementing CBWC 
1) Accuracy of the CBWC result: It’s easy to use, however it’s easy to 
make a mistake 
 
Everyone commented that the CBWC calculator was user-friendly but that it was 
prone to human error.  Data was entered manually by selecting values from a 
series of drop down boxes, so accidental or intentional mistakes could be made.  
People considered the calculator itself to be valid but were concerned with the 
accuracy of the data entered, due to the variation in how people collected, 
recorded and interpreted the data used.   
 
The audit showed that 62.7% of the time, I calculated the same CBWC result as 
what had been recorded.  Rather than implying that 37.3% of the time the 
recorded result was incorrect, what this revealed was that two people looking at 
the same data could calculate a different result more than one third of the time.  
There were a number of possible explanations for this.  Sometimes it appeared 
mistakes were made such as; selecting the wrong sex, incorrectly rounding 
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birthweight, entering weeks of gestation instead of weeks and days and 
incorrectly recording the CBWC.  In one instance, I recognised my own 
handwriting where I had recorded a CBWC of 32 instead of 23.  Tiredness, 
distractions and a busy ward can contribute to making these types of mistakes.  If 
the CBWC appears to be normal, it is unlikely the result would be re-checked.  In 
the majority of cases the CBWC would have remained within the normal range, 
so the clinical care provided would have remained the same.  While these types 
of mistakes were accidental, it was also possible to intentionally select incorrect 
data values so that a baby was no longer identified as ‘at risk’.  This in turn 
would have changed the clinical care provided. 
 
A number of people talked about seeing others ‘fix’ a CBWC result by 
manipulating a data value to make a point of difference, which would then 
change a CBWC to a normal result.  There were three instances where it 
appeared a CBWC ≥10 was recorded, so a baby was not identified as SGA, when 
the result should have been <10.  In these cases, the birthweights of the babies 
were 3180g, 3300g, and 3100g.  This showed that people were more reluctant to 
accept a CBWC result when the birthweight under the old definition would have 
been considered well within the normal range.  People also had reservations 
about the accuracy of the data itself, especially the pre-pregnancy weight, height, 
gestation and ethnicity.   
 
There was variation in the way that LMCs collected the pre-pregnancy weight 
and height.  Height was either self-reported or measured by the LMC.  Self 
reported height is usually always overestimated but within 3.5 cm of the 
measured height 75% of the time (Stewart, Jackson, Ford, & Beaglehole, 1987).  
Overestimating height decreases the CBWC value.  Many women did not know 
their pre-pregnancy weight.  Sometimes the LMC would weigh the woman at 
booking and estimate their pre-pregnancy weight, or record the gestation and 
weight at booking instead.  Commonly the booking weight was used in studies 
relating to CBWC (Gardosi, et al., 1992; McCowan, et al., 2005; McCowan, et 
al., 2004), but often this was not specified.  Booking weight is listed as the 
variable to be entered on the calculator, rather than pre-pregnancy weight, which 
is what the DHB used.  The guideline recommended using population centile 
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charts if maternal details were missing.  McCowan et al., (2004) suggested using 
average height and weight values for each ethnic group calculated from their 
study if these details were missing.  Even though some error would be 
introduced, it is more accurate that using unadjusted population standards.  When 
a data value is missing it is recommended that it should be estimated or 
population averages used, which is known as partial customisation (Gardosi, 
2009b).  In many of the studies examined, a large portion of the data could not be 
included as the maternal height and weight were not routinely recorded 
(Clausson, et al., 2001; Ego, et al., 2006; McCowan, et al., 2004).   
 
The accuracy of gestation was also questioned and whether this should be 
calculated using the woman’s last menstrual period (LMP) or by scan.  Gardosi 
and Mongelli (1993) said that using scan dates was preferable to menstrual dates 
as there was a discrepancy of seven days or more in 20% of cases.  Goldenberg 
and Cliver (1997) believed gestational age based on LMP alone is often not 
reliable as women may not always ovulate two weeks after the first day of their 
LMP.  Also some women may not pay attention to the exact date of their LMP 
and some women may have period like bleeding early in pregnancy.  One study 
showed that a dating ultrasound taken in the first half of pregnancy is generally a 
more accurate method of predicting the due date, as using ‘certain’ LMP dates 
had resulted in more women being induced for ‘postdates’ pregnancies 
unnecessarily (Mongelli, Wilcox, & Gardosi, 1996).  Gardosi (2009) 
recommends using ultrasound dates where possible even when menstrual dates 
are certain.  The majority of studies on SGA babies relied on ultrasound to define 
gestational age (Goldenberg & Cliver, 1997). 
 
Questions were also raised regarding which ethnicity to use.  Ethnicity is self-
reported and the NZ calculator has the options of choosing Chinese, European, 
Indian, Maori, Samoan, Tongan and Other.  People questioned which ethnicity to 
select if it was not included in this list.  Tips given by Professor Lesley 
McCowan for selecting ethnicity for Polynesian women are to select Maori for 
Cook Island Maori and for non-Tongan and non-Samoan women to choose 
“other”.  And where possible you can also use other calculator versions for 
different countries, to see if there is an ethnicity that is more appropriate (Cowan, 
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2009).  If multiple ethnicities are given, then ethnicity is to be prioritised in the 
order of Maori, Pacific Peoples, South East Asian, Indian, Chinese, Other Asian, 
Other, Other European and European/Pakeha as outlined by the NZ Health 
Information Service (New Zealand Health Information Service, 2007).  
 
Although the GROW software which developed the CBWC calculator is accurate 
and valid (Gardosi, 2009) the calculator itself is only as accurate as the data 
being used and the individual entering the data.  The use of the calculator in 
practice highlighted the importance of accurate record keeping, accurate data 
collection, accurate data entry and writing legibly.   
 
2) Practice improved over time: You have to experience the benefit, 
before you believe the evidence 
 
The trend of the audit was that compliance with the guideline improved over the 
audit period.  The CBWC was recorded and maternal details were collected more 
frequently.  The CBWC was calculated more accurately and there was less 
manipulation of results.  BSL were initiated more appropriately and procedures 
for LGA babies were followed more correctly.  This is in opposition to most 
literature about changing practice where changes are often not sustained, as in 
the literature around handwashing practices (Larson, Bryan, Adler, & Blane, 
1997).  But while initially challenged by having to use CBWC, compliance with 
calculating them improved over time as people began to believe the evidence.  
The results of the audit mirrored the attitudes and beliefs expressed by 
participants in the interviews and focus groups.   
 
Some of the initial resistance was partly because people felt like they were just 
told to comply and they couldn’t remember the education that had occurred 
previously.  Some people claimed that CBWC weren’t evidenced based.  This is 
a common reaction when resisting change where clinicians are quick to critically 
scrutinise the evidence so they can dismiss it, when they feel the evidence is 
being forced on to them (Fitzgerald & Dopson, 2005).  However, stakeholders 
became more comfortable with incorporating CBWC into their practice as they 
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were able to raise concerns and debate the issues.  Successful adoption of 
evidence based practice depends on local stakeholders discussing and debating 
the evidence and making joint decisions about how it is applied (Ferlie, 2005).  
This improves knowledge uptake as end users then feel a sense of ownership 
over the guideline (Harrison, Graham, & Fervers, 2009).  Decreasing the number 
of BSL was an example of a negotiated change to the guideline which helped to 
appease stakeholders. 
 
Accepting CBWC required stakeholders to redefine how SGA and LGA babies 
were identified and to move away from the cut-offs of <2500 g and >4500 g.  
The term ‘knowledge-destruction’ is used to describe how we eliminate 
knowledge.  The literature shows how it is difficult for people to destroy old 
knowledge and replace it with new knowledge (Landry, et al., 2006).  Many had 
already rejected the <2500 g and >4500 g cut-offs as arbitrary and irrelevant.  
Before knowledge leads to behavioural change, “the newer knowledge has to 
actively relate to what individuals already know, including what they know 
through their experience” (Fitzgerald, Dopson, Ferlie, & Locock, 2005, p. 156).  
Clinical experience meant practitioners had already noticed trends such as 
mothers from different ethnic groups having different sized babies and smaller 
women being predisposed to having smaller babies.  So the scene had been set 
for the knowledge around CBWC to be assimilated into practice.   
 
Identifying babies as SGA and LGA and identifying risk of hypoglycaemia were 
not new ideas.  But using CBWC to identify this risk was a novel concept.  The 
subject of hypoglycaemia was itself a controversial and contentious issue.  
Inevitably introducing CBWC as a tool to identifying risk of hypoglycaemia 
would be difficult.  When the tool identified higher birthweight babies as SGA, 
beliefs were challenged and some regressed to the old definitions of ‘normal’ 
birthweight.  But studies have shown that babies with the highest rates of 
perinatal morbidity and mortality are those identified as SGA by CBWC only 
(Clausson, et al., 2001).  The higher birthweight SGA babies that practitioners 
were challenged by were the babies that should have been monitored more 
vigilantly.  Rather than dismissing their birthweight as ‘normal’, in reality these 
were the babies at highest risk. 
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Those implementing CBWC recall the process being incredibly challenging at 
times and taking longer than expected for all stakeholders to accept the changes.  
But over time compliance improved and people readily accepted the CBWC 
result regardless of birthweight.  The resistance diminished as people 
experienced looking after babies with a ‘normal’ birthweight who were not able 
to maintain BSLs despite intervention.  Ferlie and Dopson (2005) have said that 
the visibility of outcomes influences the success rate of adoption.  The process of 
change before adopting a new practice was described by an awareness-
agreement-adoption-adherence model (Davis & Davis, 2010).  Relating this to 
CBWC, the LMC or core staff became aware of the new practice, moved through 
a process of agreement and then an adoption of CBWC to finally adhering and 
conforming to the practice (Davis & Davis, 2010).  Those who had not 
experienced this phenomenon admitted they were less convinced about the value 
of CBWC.   
 
3) Did it make a difference?: Was a case similar to the HDC scenario 
prevented? 
 
Using CBWC there were 22 babies identified as SGA and eight babies identified 
as LGA who previously would have been missed.  Details for these babies were 
outlined in Table 9 (p. 85) and Table 10 (p. 88).  It is difficult to know what 
difference was made by identifying and monitoring these additional babies.  
When evaluating any knowledge translation process, it is often difficult to find 
strong evidence to support specific changes in health care delivery (Wensing, et 
al., 2010).  It is challenging to measure how a change in practice translates into a 
change in patient outcomes (Rycroft-Malone & Bucknall, 2010a).  It is 
impossible to know whether those babies identified by CBWC only would have 
gone on to develop hypoglycaemia and/or brain damage if their care wasn’t 
proactively managed from the beginning.   
 
The NNU statistics were insufficient to measure how admissions had changed as 
a result of CBWC being implemented.  There was anecdotal evidence that there 
were no longer admissions to the NNU of babies with unexpected very low BSL.  
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There were a few examples of babies who were not able to maintain normal BSL 
despite early recognition and early intervention, who required further 
intervention in the NNU.  Perhaps in these cases we can say it did make a 
difference and possibly prevented a baby from becoming very unwell.  But in 
reality the data for these outcomes weren’t available.  To measure if 
implementing CBWC really did make a difference, it may be more appropriate to 
measure knowledge use versus the impact of knowledge use.  There are three 
ways that knowledge can be used which are: instrumental, conceptual and 
symbolic (Straus, Tetroe, Graham, Zwarenstein, & Bhattacharyya, 2009).  These 
can be measured to see whether the knowledge is making a difference, rather 
than measuring the impact of the knowledge use (Straus, Tetroe, Graham, et al., 
2009).   
 
Instrumental knowledge is about measuring the change in practitioner behaviour, 
rather than measuring a change in health status (Graham, Bick, Tetroe, Straus, & 
Harrison, 2010).  “When the implementation intervention targets a clinical 
behaviour for which there is strong evidence of benefit, it may be appropriate to 
measure outcome only in terms of whether the behaviour occurred, making 
practitioner behaviour an indicator of the outcome measure or endpoint” 
(Hakkennes & Green, 2006, p. 8).  Although clinical outcomes could not be 
measured at the patient (baby) level, the change in behaviour of stakeholders 
could be measured.  Maybe in this case, the primary outcome was compliance 
with the guideline rather than the rates of neonatal morbidity and mortality.  The 
audit demonstrated all practices relating to compliance with the guideline 
improved over the audit period.   
 
Conceptual knowledge is about using knowledge to get people to change the way 
they think about issues (Straus, Tetroe, Graham, et al., 2009).  Over time 
people’s attitudes changed and people believed calculating a CBWC had become 
routine practice.  But self efficacy was higher than what was in reality 
happening, as the audit showed there was room for improvement.  Symbolic use 
of knowledge, also known as persuasive knowledge use, has to do with using 
knowledge to influence policy (Straus, et al., 2010).  The knowledge of the 
adverse HDC event was used to persuade stakeholders that implementing CBWC 
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was urgently needed.  Although it is unknown whether calculating a CBWC 
would have actually made a difference in the outcome for the baby in the HDC 
case. 
 
One difficulty with evaluating knowledge translation processes is that often a 
clear definition isn’t given for what a clinically worthwhile improvement is 
(Majumdar, 2009).  When the DHB implemented CBWC, they hoped that it 
would prevent a scenario such as the HDC case from occurring at their hospital.  
But at the beginning of the implementation process they had not defined how this 
would be measured.  It would have been helpful to decide what the worthwhile 
clinical difference would have needed to be to consider the intervention was 
working (Majumdar, 2009).  Although specific numbers couldn’t be evaluated 
and there were no relevant statistics to compare, stakeholders believed the use of 
CBWC had made a difference.  One could easily argue that preventing a single 
baby from developing brain damage was clinically significant versus statistically 
significant.  Although this would also need to be balanced with the increased 
intervention for babies required. 
 
CBWC made a difference by introducing a more accurate method of identifying 
SGA and LGA babies.  It made a difference by changing people’s attitudes 
towards managing hypoglycaemia and the care stakeholders provided was more 
proactive.  It made a difference for those babies who required admission to the 
NNU when they weren’t able to maintain normal BSL on the postnatal ward.  
These babies were able to receive early treatment and intervention before 
becoming symptomatic.  According to the studies on customisation, these were 
the babies at highest risk of perinatal morbidity and mortality, who previously 
would have been missed. 
 
Summary 
Implementing CBWC at any maternity unit will be a challenging endeavour 
because most practitioners are unfamiliar with CBWC and hypoglycaemia is a 
controversial topic in of itself.  But the concepts behind the development of 
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CBWC, such as women of different ethnicities having different sized babies, 
supports the knowledge that practitioners have experienced in practice.  Over 
time attitudes can change which can change the way one chooses to practice.  
This can happen as practitioners recognise the value of CBWC in identifying 
babies requiring intervention that would have previously been missed.   
 
Section B: The knowledge translation framework  
1) The KTA framework is unnecessarily complex; however, 
knowledge translation is a complex process 
 
 
Figure 4.  The knowledge-to-action framework (Straus, Tetroe & 
Graham, 2009, p. 167) 
 
 
The KTA framework itself was readable and seemed to be set out in a logical, 
step-by-step manner.  It appeared user-friendly and at face value seemed to 
represent knowledge translation as a straightforward, linear process.  But the 
developers of the framework explained that “in reality, the process is complex 
and dynamic, and the boundaries between these two concepts and their ideal 
phases are fluid and permeable” (Graham, et al., 2006, p. 18).  Complexity was 
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demonstrated in the diagram by the use of double sided arrows.  But this was 
only truly understood when the framework was applied to a ‘real world’ clinical 
practice issue.  The timing of events and a number of people and processes 
facilitated knowledge translation occurring.  A closer examination of the 
literature found the authors acknowledged how potentially inadequate the 
framework could be.   
 
“While this representation suggests circularity or a sequence of 
phases that need to be taken in order, this is not how 
implementation projects unfold in “real life”.  They are often 
chaotic, and move forward in an erratic manner with continuous 
course corrections as the action phases accommodate to 
contextual factors.  Perhaps a better representation of our 
framework would be the probabilistic atomic model, where the 
action phases are like electrons around the nucleus of knowledge 
generation – and the contextual factors influence where a given 
phase might be at a specific time” (Graham & Tetroe, 2010, p. 
214) 
 
The KTA framework lacked the ability to visually represent how complex the 
process of knowledge translation truly was.   
 
The implementation of CBWC at a NZ DHB was evaluated for this research.  In 
wanting to interpret what happened in a meaningful way, the KTA framework 
was used as a research tool to help describe the knowledge translation process 
that had occurred.  Applying the KTA framework in this way was not as 
straightforward as had been presumed.  It was not as simple as merely placing 
events as they happened within the framework headings.  The reality was that the 
action phases may occur sequentially or simultaneously (Graham, et al., 2006) 
and a degree of flexibility was required when using the framework.  During the 
data analysis it was sometimes hard to separate the individual parts of the 
framework.  It was often difficult to decide which heading a particular finding 
should be placed under.  Findings often overlapped and the way each framework 
heading was defined was also open to interpretation.  In using the framework an 
obligation was felt to put data under each individual heading.  Interpreting and 
describing the implementation process using the framework became a confusing 
and frustrating exercise.  While the framework wasn’t able to visually 
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demonstrate the complexity of knowledge translation, on the other hand there 
were too many headings.   
 
By reworking the action cycle and combining headings, the KTA framework 
could have been simplified further.  In the literature, when phases in the action 
cycle were discussed, they were often combined as if they were one topic.  For 
example, ‘Adapting knowledge’ and ‘Identifying barriers’ were often discussed 
together (Straus, et al., 2008; Straus & Holroyd-Leduc, 2008).  Only subtle 
differences were found between ‘Monitor knowledge use’ and ‘Evaluate 
outcomes’ and the concept of ‘tailoring interventions’ could be likened to 
‘Adapting knowledge to local context’.  Headings and concepts could be 
combined to make a simplified version of the action cycle in the KTA framework 
(Figure 8).  This version condenses the number of headings from seven to five.  




Figure 8.  Simplified action cycle adapted from the KTA framework 
 
The nature of conceptual frameworks are that they “are in a continual state of 
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contents” (Rycroft-Malone & Bucknall, 2010b, p. 28).  Therefore, it is acceptable 
to adapt the framework as a result of this research experience.  Simplifying the 
action cycle of the framework makes it less detailed and perhaps even more user-
friendly.  But this simplified version is also unable to reflect the complexity of 
the knowledge translation process.  Although it is unable to demonstrate the 
complexity experienced within a one-dimensional diagram, the KTA framework 
is still a valuable tool.   
 
2) Knowledge translation can happen without a framework, but using 
the KTA framework can help to complete the process   
 
The DHB did not use the KTA framework when implementing CBWC at their 
maternity unit.  It was applied retrospectively as a research tool to aid with the 
data analysis.  Instead, the DHB followed their normal processes when applying 
any new evidence to a guideline eg emailing guideline changes, perinatal 
meeting presentations etc.  This demonstrated that knowledge translation can 
happen without the use of a framework.  But what a framework can do is 
highlight the ideal phases needed which can assist stakeholders to complete the 
knowledge translation process.    
 
Without using a framework the DHB were able to complete a number of the ideal 
phases proposed by the KTA framework.  But there were also a number of steps 
which weren’t done which means their knowledge translation process was 
incomplete.  Barriers to using the knowledge of CBWC were not initially 
assessed.  So the interventions employed were not specifically designed to 
address any potential barriers stakeholders might have to implementing CBWC 
into their practice.  Routine processes were followed for updating any guideline 
or policy at the DHB.  But Wensing et al., (2010) explained that it is important 
that knowledge translation interventions are specifically tailored to barriers, in 
the same way that a clinical treatment is tailored to a specific health problem.  
The level of opposition to CBWC was unexpected.  By tailoring the interventions 
perhaps it wouldn’t have taken as long for stakeholders to accept the evidence.  
After implementing CBWC nothing had been done to formally monitor 
knowledge use, evaluate outcomes and sustain knowledge use.  The Midwifery 
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Educator had wanted to evaluate outcomes but was unable to.  Often the 
predicament is having the time and funding to properly assess change processes 
(Davies & Edwards, 2009).  It is also acknowledged that sustainability is rarely 
addressed even though it is recommended in the early stages when interventions 
are being designed (Davies & Edwards, 2009).   
 
This research attempted to complete the knowledge translation process by 
undertaking the phases of the action cycle that had not been done.  But this 
wasn’t entirely possible as the required data wasn’t available.  It was not possible 
to truly evaluate what difference, if any, implementing CBWC had made on the 
numbers of babies experiencing morbidity and mortality relating to 
hypoglycaemia.  Ideally applying a framework early in an implementation 
process can help to guide the process and focus attention on what is important 
(Rycroft-Malone & Bucknall, 2010a).  In this way decisions can be made from 
the beginning about what outcomes are most important and what data needs to be 
collected to be able to measure this.   
 
The DHB did not need to use a framework to facilitate implementing CBWC.  
But the knowledge translation process was incomplete because the DHB did not 
evaluate whether CBWC were being used as it was intended and did not evaluate 
the outcomes resulting from the change in practice.  This is where a framework 
may have been helpful.  Frameworks should facilitate, not constrain the 
implementation process (Rycroft-Malone & Bucknall, 2010a).  It can help you 
know what is required to make the process complete.  When used at the planning 
stages of implementation it can illustrate what is needed to complete the process.  
But one thing that did become evident from the implementation process at the 
DHB was the need for a champion. 
 
3) A champion facilitates the knowledge translation process 
A champion facilitates knowledge translation by maintaining the momentum 
needed to advance change.  It is important that organisations invest in someone 
who is responsible for ensuring that midwifery practice is evidence-based, as 
change cannot occur without a champion (Melnyk, Fineout-Overholt, Stone, & 
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Ackerman, 2000).  Identifying people who are enthusiastic about the issue, can 
help sell new ideas (Rycroft-Malone & Bucknall, 2010a).  In this knowledge 
translation process the champion was the Midwifery Educator.   
 
The Midwifery Educator was the person mainly responsible for updating clinical 
guidelines at the maternity unit.  In addition to facilitating all Quality related 
events, she worked clinical shifts.  Her workload would have been covered by a 
number of employees at a larger DHB.  When she first heard about CBWC 
through her role as the local PMMRC Coordinator, she investigated how it might 
be used at the maternity facility to help better identify SGA and LGA babies.  
After consulting with stakeholders she included CBWC in the relevant 
guidelines.  But it wasn’t until staff and LMCs were expected to start calculating 
a CBWC for every birth that people starting opposing the change.  With the 
timely release of the HDC findings and the UNICEF guidance document, the 
opportunity presented itself to fully implement CBWC through further 
facilitating a variety of interventions.  The Midwifery Educator was identified by 
all stakeholders as being instrumental in the whole process.  Undoubtedly 
without her hard work CBWC wouldn’t have been put into action at the DHB. 
 
Summary 
Knowledge translation is a complex process that is facilitated by a number of 
phenomena, including a champion.  It can happen without the use of a 
framework.  But what using a simple framework can do is help to identify the 
phases required to complete the process.   
 
Section C: Reflections on the research as a whole 
1) It was not possible to do a process-outcome evaluation 
Chapter Four (p. 36) outlined the research approach, design and methods used.  
The research was described as a process-outcome evaluation.  The aim was to 
evaluate peoples experiences of the events that occurred and the extent to which 
processes were being followed correctly, as well as evaluating outcomes 
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resulting from introducing CBWC.  Although the intention was to perform a 
process-outcome evaluation, in reality, the study was a process evaluation.  The 
data wasn’t there to evaluate if CBWC actually did improve clinical outcomes 
and make a difference for babies.  It was unknown whether any scenarios, similar 
to the HDC case, had been prevented since CBWC were implemented.  
Evaluating the extent to which the program was implemented was able to explain 
some of the outcomes of the audit (Owen, 2006).  But it was not possible to 
evaluate the real difference it made in influencing the rates of perinatal morbidity 
and mortality relating to neonatal hypoglycaemia, which was disappointing.   
 
2) Using CBWC facilitated a proactive approach to managing 
hypoglycaemia and made practitioners more aware of the bigger 
picture of risk assessment 
 
Using CBWC to identify SGA and LGA babies was just one factor to consider in 
identifying babies at risk of hypoglycaemia.  In the beginning, CBWC was the 
only issue people focused on during some heated discussions at perinatal 
meetings.  Those implementing CBWC explained that the changes in the 
guidelines weren’t just about CBWC.  The changes were also about the bigger 
picture of risk assessment and the DHB being more proactive in their approach to 
managing neonatal hypoglycaemia.   
 
The CBWC result was included in a flowchart used for the ongoing assessment 
of babies at risk of hypoglycaemia (Appendix L).  The flowchart stressed that 
babies should be reviewed prior to each feed for 24 - 48 hours, even after two 
normal BSLs were recorded.  Feeding charts (Appendix M) were also used 
which required staff to assess the quality of each breastfeed.  Both of these tools 
emphasised a proactive management approach towards babies at risk of 
hypoglycaemia.  There was a recognition that since the introduction of CBWC, 
stakeholders were more aware of hypoglycaemia and were intervening before a 
baby become symptomatic.  Eventually, people viewed the CBWC as more than 
just a number and saw how it related to the environment in which the baby was 
expected to thrive.  People began to see how a baby’s CBWC related to the 
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bigger picture of risk assessment and the care and education provided in the 
antenatal, intrapartum and postnatal periods.   
 
Stakeholders began to understand that CBWC wasn’t just about hypoglycaemia.  
They noticed relationships between CBWC and smoking, obesity, diet, diabetes 
screening, drugs and alcohol in pregnancy and safe sleeping messages.  The 
CBWC seemed to correlate with high risk birthing groups as 75.8% of SGA 
babies were born to Maori mothers.  Maori pregnant women are over-represented 
in socioeconomic deprived areas (New Zealand Health Information Service, 
2007).  Smoking rates for Maori women of childbearing age are more than 
double that of non-Maori, peaking at 61% for women between the ages of 20 - 24 
years (The Quit Group and the Ministry of Health, 2009).  The rates of Maori 
babies dying of SUDI (Sudden Unexplained Death in Infancy) are significantly 
higher than other ethnic groups (Child and Youth Mortality Review Committee, 
2009).  Gestational diabetes is diagnosed in 6% of pregnant Maori women, which 
is double that of NZ European women (Health Research Council of New 
Zealand, 2010).  Maori women are “1.7 times more likely to be obese than … 
women in the total population” (Ministry of Health, 2008, p. 111).  Although not 
audited, it would have been interesting to have investigated the smoking status, 
socioeconomic status and other health risk behaviours of the women having a 
SGA baby.  Obesity is defined as a BMI>30 kg/m2 (C. T. R. U. Ministry of 
Health, 2009).  In the study 31.8% (7/22) of mothers with a SGA baby identified 
by CBWC only, were obese and 62.5% (5/8) of the mothers having a LGA baby 
identified by CBWC only, were obese.  Maternal obesity in pregnancy is 
associated with many risks (Yu, Teoh, & Robinson, 2006).  People recognised 
these types of risk factors were often associated with the mothers of babies 
identified by CBWC as SGA or LGA. 
 
When a baby was born with a CBWC of 0, people would ask whether a CGC 
chart was completed antenatally.  People questioned why the baby failed to grow 
to its optimum size and what factors were involved.  These cases were often 
discussed at perinatal meetings, especially when there was a poor outcome for 
the baby.  The discussions were around whether a low CBWC was expected and 
what could have been done differently.  Babies born with a low CBWC 
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reinforced the importance of using CGC charts in pregnancy for those LMCs 
who weren’t routinely using them as had been recommended.     
3) Reflection on the HDC case 
The implementation of CBWC was described by an LMC as a “knee jerk 
reaction” to the HDC case which was based on “fear”.  Although CBWC had 
already been included in the relevant guidelines, the HDC report acted as the 
catalyst to accelerate the implementation process.  Areas chosen for policy 
development are often in response to an adverse incident.  Policy is then 
developed outlining how a specific practice matter should be approached which 
aims to prevent future incidents (Boogaerts, Grealish, & Ranse, 2008).  Some 
criticise that this can be limiting when the response is to a single event “where 
professional judgement (or lack thereof) may have been a significant factor” 
(Boogaerts, et al., 2008, p. 52).  The HDC case was a single event which 
occurred at another DHB.  But the Clinical Director of Child Health was charged 
by the clinical board to show how a case such as this would be prevented at their 
DHB.  Using CBWC became one answer presented to the clinical board to better 
identify babies at risk of hypoglycaemia.   
 
It is unclear whether calculating a CBWC would have even made a difference in 
the HDC case.  Maternal details were not given in the report, so a CBWC could 
no be calculated.  Sex-adjusted population based centiles used at the DHB in this 
study gave a BWC sitting around the 10th centile (Appendix O).  The baby was 
delivered by emergency caesarean section due to foetal distress in early labour.  
There were concerns around whether the baby had adequate reserves to tolerate a 
long labour.  The Apgars were 7 at one minute and 10 at five minutes and the 
baby received facial oxygen.  The mother was taking the anti-depressant Aropax, 
so the baby was at risk of hypoglycaemia, regardless of its birthweight.  Aropax 
is not recommended in pregnancy unless the potential benefit for the mother 
outweighs the possible risk to the baby (GlaxoSmithKline NZ Ltd, 2010).  It is 
recommended that babies of mothers on Aropax are observed closely for 
hypoglycaemia and that complications were most likely to occur in the first 24 
hours (GlaxoSmithKline NZ Ltd, 2010).  The mother was also a smoker.  The 
baby most likely would have had normal BSLs in the first 24 hours as it was 
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initially feeding well.  By Day three it was symptomatic of hypoglycaemia, but it 
is unknown how long a baby can be hypoglycaemic before becoming 
symptomatic (World Health Organization, 1997).  The hypoglycaemia had gone 
unrecognised and the baby deteriorated to the point of becoming brain injured, 
despite late intervention.  There were several factors, other than the baby’s 
birthweight, which may have contributed to the baby’s inability to produce an 
appropriate metabolic and endocrine response to counterregulate the 
hypoglycaemia that occurred (Cornblath, et al., 2000).  The baby’s birthweight 
may not have been the greatest risk factor for hypoglycaemia.  Calculating a 
CBWC alone may have not made a difference, as other risk factors were also not 
identified.   
 
When a policy is developed in reaction to an adverse event occurring this can 
sometimes obscure the real issue which is often the cause of the incident 
(Boogaerts, et al., 2008).  The HDC report played a significant role in facilitating 
CBWC to be fully implemented at the DHB, as a proposed way to prevent a case 
such as this occurring at their hospital.  But it is unknown whether calculating a 
CBWC would have really made a difference in this scenario.  The real issue 
might have been in the delay in recognising the baby was no longer feeding 
appropriately and the non-recognition of a number of factors that put the baby at 
risk of hypoglycaemia.  The introduction of any instrument is only effective 
when used in conjunction with good clinical observations and judgment.  The 
midwifery expert and Commissioner discussed the use of CGC as a better guide 
to identify babies at risk.  But in the context of this case, what they actually 
should have been recommending was the calculating of a CBWC at birth, as they 
were discussing identifying birthweight as a risk factor for hypoglycaemia.  So 
even the experts were unsure as to what they were referring to.  This showed how 
unfamiliar people were with using CGC and CBWC in clinical practice. 
4) Reflection on conducting the research 
I wanted to do a Masters thesis so I could gain the experience of completing a 
piece of research.  I was naively unaware of how challenging the process would 
be.  From initially writing a research proposal and gaining ethical approval, to 
collecting and analysing data, to discussing findings and results, I often felt like I 
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was stumbling along the way.  The biggest lesson learned was that research takes 
much longer than expected and I was constantly having to adjust the research 
timeline I had set myself.  I believe that this research project has given me a new 
set of skills which will aid me in my future educational and professional 
endeavours.  Overall, I felt the research went well and despite the challenges I 
accomplished what I wanted to achieve.  Completing this research ended up 
being more about the journey and the learning acquired along the way, as much 
as it was about CBWC, evaluation and knowledge translation.  This thesis has 
shown me that I can transform data into something meaningful, which can be 
applied in a practical way to the clinical environment and contribute to the field 
of midwifery knowledge. 
 
Limitations 
The study was limited by its size and scope.  This was a small scale research 
study completed to fulfill the requirements of a Masters Thesis.  The findings of 
the study may not be applicable in other scenarios such as a larger DHB with 
differing population characteristics.  If fewer methods were employed I perhaps 
would have been able to achieve a more in-depth analysis and discussion rather 
than an overview of several areas.  Several methods were required to answer all 
of the objectives I wanted to achieve.  No statistical analysis was performed as 
the audit sample size of 303 births was likely too small to determine statistical 
significance and was beyond the scope of the research project.   
 
Stakeholders were most interested in learning whether the use of CBWC had 
made a difference by reducing neonatal morbidity and mortality associated with 
hypoglycaemia.  Determining this outcome was unachievable as the data wasn’t 
available to answer the question.  It would have required the NNU recording 
more specific data around the reasons for admissions relating to hypoglycaemia.  
This was unfortunate as one of the main reasons why it was implemented and the 
Clinical Director of Child Health was so passionate about it, was that the DHB 
wanted to prevent babies developing brain damage related to hypoglycaemia.  
But anecdotally it appeared no babies with really low unexpected BSLs were 
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being admitted to the NNU and no one remembered a baby sustaining a brain 
injury relating to hypoglycaemia. 
 
One disappointment was that the Clinical Director of Child Health was not 
forthcoming to be interviewed.  He commented that he would have nothing 
further to add from what could be obtained from the other interviews.  He said 
that his role was to only support the Midwifery Educator and NNU Quality 
Coordinator in the writing of the relevant guidelines.  It is unknown why the 
Clinical Director minimised his role in the process, as he was highlighted by 
many stakeholders as a key person to talk to.  Nobody knew why this HDC case 
specifically was highlighted by the clinical board or whether it was just standard 
practice to review all HDC cases.  The Clinical Director would have been able to 
answer this question and shed light on other aspects of the implementation 
process.   
 
Although the sample size was small, the research still contributes to the 
knowledge around the practical use of CBWC in a clinical environment.  It also 
makes a contribution by commenting on the usefulness of applying the KTA 
framework to a clinical practice issue.   
 
Section D: Significance/Recommendations/Ideas for further 
research 
1) Significance 
It was recognised that “further studies in other populations are required to 
determine the generalisability of these earlier studies of customised centiles and 
their role in prediction of morbidity in general populations” (McCowan, et al., 
2005, p. 1027).  This research was a small scale study and was only able to 
provide anecdotal evidence that using CBWC decreased neonatal morbidity at 
the DHB.  But there still appeared to be a number of firsts associated with the 
research. 
 
This was the first piece of research to investigate the use of CBWC as an 
assessment tool for identifying babies at risk of developing hypoglycaemia due 
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to birthweight.  This research was also the first to explore issues relating to the 
practical application of the CBWC calculator at a maternity unit and the 
challenges involved with changing the way people practiced.  This research was 
also unique in that it applied the KTA framework retrospectively to a clinical 
practice issue and was able to comment on the usefulness of using the KTA 
framework in this way.     
 
2) Recommendations 
Calculating a CBWC relies on accurate data entry.  The calculator requires users 
to select data values from a series of drop down menus and mistakes can easily 
be made.  Incorrect data values can also be purposefully selected to manipulate a 
CBWC result so a baby no longer requires BSL monitoring.  To remove the 
temptation to change a result, it would be useful if the computer system allowed 
for a woman’s booking visit data to be pre-entered.  At the time of birth the 
gestation would be automatically calculated and only the birthweight and baby’s 
sex would be entered to generate the CBWC.  The hospital computer system was 
not designed this way.  But I have worked at another DHB where the mother’s 
booking information is pre-entered, which makes it more difficult for 
practitioners to go back and change the original data entered.  Double checking 
data entry would also help to decrease the number of mistakes.  
 
The Maternity Unit Manager had emailed other maternity managers in NZ to 
enquire what methods were being used to identify SGA and LGA babies.  From 
the few responses received, she learned other DHBs were using the <2500 g and 
>4500 g cutoffs, or a chart with cut-off weights for varying gestations based on 
population BWC charts.  No other DHBs were using CBWC.  The evidence 
shows that using customised centiles is preferable to using population based 
centiles (Ego, et al., 2006).  So using CBWC is more desirable than using cut-off 
weights based on population BWC charts.  The evidence that gestation influences 
whether a birthweight should be considered ‘normal’ (World Health 
Organization, 1961) indicates that no DHB in NZ should be using the cut-off 
points of <2500 g and >4500 g to identify SGA or LGA babies.  These values are 
arbitrary and out-dated and do not take into consideration a number of variables 
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which are known to affect the potential optimal growth of a baby, most 
importantly gestation and maternal weight.  Using these out-dated cut-off points 
will result in a number of ‘at risk’ babies being missed. 
 
The LMC should consider calculating a CBWC as part of the initial newborn 
assessment and part of the primary care provided.  The LMC should be aware of 
the CBWC result before handing over care of the baby to core staff.  This 
requires the LMC to either calculate the CBWC themselves or to ask a staff 
member to assist them.  The LMC should be the one who informs the woman and 
her family of a CBWC result if the baby requires BSL monitoring.  The LMC 
should also initiate the appropriate paperwork and care plan and forward this 
information to core staff.  Where the woman has been handed over to secondary 
care prior to or during labour, the core staff would take over these 
responsibilities.  If LMCs and core staff communicate their roles clearly and 
work as a team, there will be less missed opportunities where the calculating of a 
CBWC is delayed.          
 
If the Perinatal Maternal Mortality Review Committee recommend CGC to be 
completed for all pregnancies in NZ, then it is reasonable to recommend 
calculating a CBWC for every birth.  The evidence which lead to the 
development of the GROW software is valid for both CGC and CBW.  A CGC 
can only predict birthweight and estimate growth restriction and macrosomia, 
whereas a CBWC is calculated using the actual birthweight.  If customisation is a 
valid argument for the provision of antenatal care, then it should be considered 
just as valid in the postnatal period.  If practitioners are expected to act upon the 
results of plotted CGC charts in pregnancy, then they should be expected to act 
upon the results of a CBWC calculated at birth.  The two are not mutually 
exclusive.  Completing both a CGC and calculating a CBWC will help to 
determine how closely correlated the two results are.   
 
When implementing new evidence into a guideline, using a knowledge 
translation framework can help stakeholders to identify all the steps required to 
complete the process.  This is particularly important when the evidence involves 
an unknown or novel practice.  Identifying a ‘champion’, who is supported by 
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management, is also crucial in facilitating the implementation process.  Also any 
major change in a guideline should be evaluated within a given time period, to 
assess whether processes are occurring as intended and whether the outcomes are 
producing the desired results. 
 
These recommendations highlight the need for further research to be conducted 
to identify the difference that CBWC really makes. 
 
3) Ideas for further research 
There are numerous opportunities for further research relating to the use of 
CBWC in clinical practice and the relatively new field of knowledge translation.   
 
If CBWC are to be used as a method for determining the risk of SGA and LGA 
babies developing hypoglycaemia, then more research needs to be performed to 
provide the evidence for defining monitoring threshold limits.  The DHB studied 
monitored babies with a CBWC <10 or >95 (where the mother had not had a 
negative diabetes screen in pregnancy).  But it is possible that these thresholds 
could be narrowed, for example to <5 or >97.  But further research is needed to 
determine what these cut-off points could safely be.   
 
Research needs to be performed to determine the correlation between fundal 
height measurements on a CGC and the CBWC at birth.  This way the predicted 
birthweight can be compared to the actual birthweight.  This will confirm how 
accurate the CGC are in determining birthweight based on plotted fundal height 
measurements.   
   
The KTA framework needs to be applied in more clinical practice settings which 
may further validate the use of the framework as a clinical practice tool.  Ideally 
the framework would be applied in a prospective, longitudinal manner, so that 
the different phases of the implementation process can be informed as it happens 
(Spyridonidis & Calnan, 2011).  In this study the framework was not used by the 
DHB, but it was applied retrospectively to aid with the data analysis and 
presentation of the knowledge translation story.   
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Conclusion: Revisiting the Research Question 
 
The first aim of this study was to identify and critique the evidence relating to the 
use of CBWC.  The evidence demonstrates that using customised standards 
versus population based standards, improves the identification of babies at 
greater risk of perinatal morbidity and mortality.  The literature showed that the 
variables gestation and maternal weight have the greatest physiological effect on 
birthweight.  Ethnicity, maternal height, parity and the baby’s sex also have a 
significant effect on birthweight.  Smoking has a significant pathological effect 
on optimal foetal growth and was not included in the development of the GROW 
software.  GROW was used to create CGC and the CBWC calculator.  While the 
evidence supporting the use of CBWC has been available for a number of years, 
they are not commonly used within NZ DHBs.  There has been a delay in getting 
this knowledge translated into action. 
 
The second aim of this study was to describe how CBWC were implemented at 
one NZ DHB.  Data from interviews and focus groups formed the basis of the 
implementation story and additional documentation helped to verify specific 
events and dates.  A knowledge translation framework was used retrospectively 
to provide a theoretical foundation and describe the process in a meaningful way.  
The Midwifery Educator was the champion who facilitated various interventions 
to implement CBWC.  CBWC became fully implemented after the release of a 
HDC report and a UNICEF guidance document, which catalysed the momentum 
required for this to happen. 
 
The third aim of the study was to evaluate the processes followed when utilising 
CBWC.  Qualitative data described the attitudes and beliefs of stakeholders 
towards CBWC and an audit was conducted to see if the guideline was being 
followed correctly.  Initially practitioners were challenged by the evidence for 
CBWC, especially when babies of ‘normal’ birthweight were being identified as 
SGA or LGA.  But over time people came to accept the CBWC result regardless 
of birthweight, when they experienced caring for babies who were unable to 
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maintain normal BSL despite early intervention.  This was mirrored by the audit 
results where compliance to the guideline improved over time.   
 
The fourth aim of the study was to identify outcomes relating to the babies 
identified as SGA or LGA using CBWC.  It was unknown whether perinatal 
mortality and morbidity had decreased since implementing CBWC, as the 
appropriate data was not available.  But the DHB had become more proactive in 
their management of hypoglycaemia and identifying risk.  Practitioners were 
intervening earlier instead of waiting for babies to become symptomatic.  There 
was anecdotal evidence that using CBWC was making a difference in identifying 
babies who would have previously been missed.  It is unknown whether a 
scenario similar to the HDC case had been prevented, although there were some 
examples of possible near misses found in the audit.   
 
The fifth aim of the study was to evaluate the usefulness of the knowledge-to-
action Framework when applied to a clinical practice issue.  Applying the 
framework in a retrospective manner was sometimes difficult and confusing.  
This highlighted the fact that knowledge translation is a complex process which 
is inadequately demonstrated by a one-dimensional diagram.  But what using a 
framework can do is identify the ideal phases needed for knowledge translation 
to be completed.  It also highlighted the importance of a champion to facilitate 
the implementation process. 
 
The significance of this study relates back to the original research question which 
was: 
 
How was the evidence behind the use of CBWC put into practice at one NZ 
DHB and what are the outcomes resulting from translating this knowledge into 
action? 
 
Although this research is a small-scale evaluation, it contributes to knowing how 
the evidence for CBWC can be translated into action.  This is the first study 
which describes the practical application of CBWC in a clinical practice setting.  
Consequently, this research may be of interest to other maternity units who are 
  119 
considering whether to implement CBWC.  But there are still a number of issues 
around CBWC that need to be explored.  This includes determining the 
appropriate cut-off points to be used to identify SGA and LGA babies by CBWC 
and identifying the real difference CBWC makes in reducing morbidity and 
mortality outcomes for babies at risk of hypoglycaemia.   
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